Florida International University

FIU Digital Commons
FIU Electronic Theses and Dissertations

University Graduate School

3-27-2015

Fiber Scaffolds of Poly (glycerol-dodecanedioate)
and its Derivative via Electrospinning for Neural
Tissue Engineering
Xizi Dai
Florida International University, xdai001@fiu.edu

DOI: 10.25148/etd.FI15032147
Follow this and additional works at: https://digitalcommons.fiu.edu/etd
Part of the Biomaterials Commons, and the Molecular, Cellular, and Tissue Engineering
Commons
Recommended Citation
Dai, Xizi, "Fiber Scaffolds of Poly (glycerol-dodecanedioate) and its Derivative via Electrospinning for Neural Tissue Engineering"
(2015). FIU Electronic Theses and Dissertations. 1852.
https://digitalcommons.fiu.edu/etd/1852

This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in
FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact dcc@fiu.edu.

FLORIDA INTERNATIONAL UNIVERSITY
Miami, Florida

FIBER SCAFFOLDS OF POLY (GLYCEROL- DODECANEDIOATE) AND ITS
DERIVATIVE VIA ELECTROSPINNING FOR NEURAL TISSUE ENGINEERING

A dissertation submitted in partial fulfillment of the
requirements for the degree of
DOCTOR OF PHILOSOPHY
in
BIOMEDICAL ENGINEERING
by
Xizi Dai
2015

To: Dean Amir Mirmiran
College of Engineering and Computing
This dissertation, written by Xizi Dai, and entitled Fiber Scaffolds of Poly
(glycerol-dodecanedioate) and its Derivative via Electrospinning for Neural
Tissue Engineering, having been approved in respect to style and intellectual
content, is referred to you for judgment.
We have read this dissertation and recommend that it be approved.

_______________________________________
Anthony J. McGoron
_______________________________________
Lidia Kos
_______________________________________
Nikolaos Tsoukias
_______________________________________
Wei-Chiang Lin, Major Professor
Date of Defense: March 27, 2015
The dissertation of Xizi Dai is approved.

_______________________________________
Dean Amir Mirmiran
College of Engineering and Computing

_______________________________________
Dean Lakshmi N. Reddi
University Graduate School
Florida International University, 2015

ii

DEDICATION
I would like to dedicate this dissertation to my husband Adnan Ismail, my
parents, my uncle and aunt, who have been fully supportive and helped me
throughout this journey. I want to thank my husband, with whom, as newly-weds,
I navigated the last year of my Ph.D. Thanks to your support and encouragement,
I have been able to overcome both expected and unexpected obstacles during
the last few years. Thank you for being my human spell-check, for being by my
side every weekend in the lab, and for always knowing what to do and say when
the going gets tough. I want to thank my parents who brought me into this world
and have been always there for me. Whose many sacrifices for my sake, their
only child, can never be repaid. Who supported my decision, even when it pained
them, as long as it made me happy. I would also like to thank my uncle and aunt,
who supported me and stood by me after my operation, and where my shining
light during the darkest days of my life in the United States. I cannot express my
gratitude for having them by my side, when I was most lonely and helpless, and I
will never forget they were here for me when I needed them.
No one says that the life of a Ph.D. candidate is an easy one, and I came to
understand why. There were so many moments when I just wanted to give up
and walk away, but thanks to the support of my friends and family, I persevered.
Looking back at the past five years of my life, I realize that they offered me the
most valuable experience of my life, not only because they led to a doctoral
degree, but mainly because they taught me how to solve problems, how to work
with people, how to deal with stress, and how to never give up.

iii

ACKNOWLEDGMENTS
I would like to acknowledge my mentor Dr. Yen-Chih Huang for his
guidance and mentoring through all these years. He taught me how to become a
real scientist and showed me the right attitude toward science. He has always
had my best interest at heart and provided me with every opportunity to learn. I
really appreciate all the patience and kindness that he has shown me over these
past five years, even after he left the department. I also want to thank Dr. WeiChiang Lin, who took over as my advisor following Dr. Huang’s departure, for his
great support in the last year of my Ph.D. career. Without his help, there is no
way I could have finished my experiments and graduate on time. I would also like
to thank my dissertation committee members Dr. Anthony J. McGoron, Dr. Lidia
Kos and Dr. Nikolaos Tsoukias for their invaluable feedback and advice to steer
me in the right direction of my research and improve my dissertation. I want to
thank the lab manager Yun Qian, who helped me a lot with managing the lab
supplies during the last two semesters. I also want to thank my labmates Jared
Leichner, Emily Chereson and Anh Lee, who rallied to my help during the difficult
period following Dr. Huang’s departure.
I would also like to acknowledge the financial support and funding during
my Ph.D. studies provided by a Teaching Assistantship from the Biomedical
Engineering Department at FIU from 2009-2015 that made this moment possible.
I truly thank all of you from the bottom of my heart.

iv

ABSTRACT OF THE DISSERTATION
FIBER SCAFFOLDS OF POLY (GLYCEROL- DODECANEDIOATE) AND ITS
DERIVATIVE VIA ELECTROSPINNING FOR NEURAL TISSUE ENGINEERING
by
Xizi Dai
Florida International University, 2015
Miami, Florida
Professor Wei-Chiang Lin, Major Professor
Peripheral nerves have demonstrated the ability to bridge gaps of up to 6
mm. Peripheral Nerve System injury sites beyond this range need autograft or
allograft surgery. Central Nerve System cells do not allow spontaneous
regeneration due to the intrinsic environmental inhibition. Although stem cell
therapy seems to be a promising approach towards nerve repair, it is essential to
use the distinct three-dimensional architecture of a cell scaffold with proper
biomolecule embedding in order to ensure that the local environment can be
controlled well enough for growth and survival. Many approaches have been
developed for the fabrication of 3D scaffolds, and more recently, fiber-based
scaffolds produced via the electrospinning have been garnering increasing
interest, as it offers the opportunity for control over fiber composition, as well as
fiber mesh porosity using a relatively simple experimental setup. All these
attributes make electrospun fibers a new class of promising scaffolds for neural
tissue engineering. Therefore, the purpose of this doctoral study is to investigate
the use of the novel material PGD and its derivative PGDF for obtaining fiber

v

scaffolds using the electrospinning. The performance of these scaffolds,
combined with neural lineage cells derived from ESCs, was evaluated by the
dissolvability test, Raman spectroscopy, cell viability assay, real time PCR,
Immunocytochemistry, extracellular electrophysiology, etc. The newly designed
collector makes it possible to easily obtain fibers with adequate length and
integrity. The utilization of a solvent like ethanol and water for electrospinning of
fibrous scaffolds provides a potentially less toxic and more biocompatible
fabrication method. Cell viability testing demonstrated that the addition of gelatin
leads to significant improvement of cell proliferation on the scaffolds. Both real
time PCR and Immunocytochemistry analysis indicated that motor neuron
differentiation was achieved through the high motor neuron gene expression
using the metabolites approach. The addition of Fumaric acid into fiber scaffolds
further promoted the differentiation. Based on the results, this newly fabricated
electrospun fiber scaffold, combined with neural lineage cells, provides a
potential alternate strategy for nerve injury repair.

vi

TABLE OF CONTENTS
CHAPTER

PAGE

CHAPTER 1 Introduction ...................................................................................... 1
1.1 Preface ........................................................................................................ 1
1.1.1 Nerve Injury........................................................................................... 1
1.1.2 Neural tissue engineering ..................................................................... 3
1.2 Background ................................................................................................. 5
1.2.1 Scaffold ................................................................................................. 5
1.2.1.1 Poly (glycerol- dodecanedioate) ..................................................... 5
1.2.1.2 Fabrication methods ....................................................................... 8
1.2.2 Stem cells and its differentiated neurons ............................................ 15
1.2.2.1 Teratomas, pluripotent stem cells, and mouse embryonic stem
cells .......................................................................................................... 16
1.2.2.2 Human embryonic stem cells ........................................................ 16
1.2.2.3 Induced pluripotent stem cells ...................................................... 18
1.2.2.4 Neural stem cells, neurons and glial cells ..................................... 19
1.2.2.5 Motor neuron ................................................................................ 21
1.3 Current research of cellular interactions on electrospun scaffolds for
neural tissue engineering ................................................................................ 24
1.4 Research Plan ........................................................................................... 26
CHAPTER 2 Efficient and Low-Cost Differentiation of Embryonic Stem Cells
into Motor Neurons by Metabolites for Neural Tissue Engineering ..................... 29
2.1 Introduction ............................................................................................... 29
2.2 Experimental ............................................................................................. 34
2.2.1 Motor Neuron Induction from Mouse Embryonic Stem cells ............... 34
2.2.2 Functional evaluation of motor neuron differentiation.......................... 35
2.2.2.1 Reverse Transcription-Polymerase Chain Reaction ..................... 35
2.2.2.2 Immunocytochemistry ................................................................... 36
2.2.2.3 Evaluation of cellular viability ........................................................ 36
2.2.2.4 Extracellular Electrophysiology ..................................................... 37
2.3 Results ...................................................................................................... 38
2.3.1 Efficient motor neuron induction from embryonic stem cells ............... 38
2.3.1.1 Schematic procedures of motor neuron differentiation ................. 38
2.3.1.2 RA Increases the Cell Viability and Restricts ESCs into Neuronal
Lineage ..................................................................................................... 40
2.3.1.3 The Effect of NaB on the Conversion of ESCs into Neural Stem
Cells. ......................................................................................................... 43
2.3.1.4 Continued Presence of Genistein and NaF Promotes Motor
Neuron Generation. .................................................................................. 44
2.3.1.5 Effects of Various Combinations of Three Metabolites ................. 47
2.3.1.6 Purmorphamine Replaces SHH for Motor Neuron Differentiation. 48
2.3.1.7 Functional Features of ESC derived Motor Neuron. ..................... 50

vii

2.4 Discussion ................................................................................................. 54
CHAPTER 3 Development of Electrospun Fiber Scaffolds using Poly (glyceroldodecanedioate)/Gelatin Blended for Neural Tissue Engineering ...................... 60
3.1 Introduction ............................................................................................... 60
3.2 Experimental ......................................................................................... 64
3.2.1 Determination of PGD molecular weight by Gel Permeation
Chromatography (GPC)/Size Exclusion Chromatography (SEC)................. 64
3.2.2 Preparation of PGD/gelatin polymer solution and fabrication of
electrospinning fibers ................................................................................... 65
3.2.3 Characterization of PGD/gelatin fiber scaffolds ................................... 67
3.2.3.1 Scanning electron microscopy (SEM) of Electrospun fibers ......... 67
3.2.3.2 Raman spectroscopy .................................................................... 67
3.2.3.3 Dissolvability test .......................................................................... 67
3.2.4 In vitro studies of PGD/gelatin fibers with human foreskin fibroblasts . 68
3.2.4.1 Cell seeding .................................................................................. 68
3.2.4.2 Visualization of cells on the fibers ................................................. 68
3.2.4.3 Evaluation of cellular viability ........................................................ 69
3.2.5 Statistics.............................................................................................. 69
3.3 Results .................................................................................................. 70
3.3.1 Characterization of PGD polymer ....................................................... 70
3.3.1.1 Determination of PGD molecular weight ....................................... 70
3.3.1.2 Raman spectroscopy .................................................................... 71
3.3.2 Characterization of PGD/gelatin electrospun fibers ............................ 72
3.3.2.1 The newly designed collector and the effects of PGD
concentration on fiber size ........................................................................ 72
3.3.2.2 Raman spectroscopy .................................................................... 75
3.3.2.3 Fiber dissolvability ........................................................................ 76
3.3.3 In vitro studies of PGD/gelatin fiber scaffolds ...................................... 77
3.3.3.1 Visualization of cells on fiber scaffolds ......................................... 77
3.3.3.2 Cell viability ................................................................................... 78
3.4 Discussion ................................................................................................. 79
CHAPTER 4 Modification of Electrospun Fiber Scaffolds Composed of PGDF
for Neural Tissue Engineering. ........................................................................... 83
4.1 Introduction ............................................................................................... 83
4.1.1 Embedding Biomolecules into fiber Scaffolds for Neural Tissue
Regeneration ............................................................................................... 83
4.1.2 Functions of poly (glycerol- dodecanedioate co-fumarate).................. 84
4.1.3 Peptides modification on the synthetic polymers ................................ 86
4.2 Experimental .......................................................................................... 87
4.2.1 PGDF fiber design and fabrication ...................................................... 87
4.2.2 Characterization of PGDF fiber scaffolds ............................................ 89
4.2.2.1 SEM .............................................................................................. 89
4.2.2.2 Dissolvability test .......................................................................... 89

viii

4.2.2.3 FA Release Behaviors of Electrospun fiber .................................. 89
4.2.2.4 Raman spectroscopy .................................................................... 90
4.2.2.5 Peptides Immobilization ................................................................ 90
4.2.3 In vitro studies of PGDF fibers with mouse embryonic stem cells ....... 90
4.2.3.1 Cell seeding and distribution ......................................................... 90
4.2.3.2 Cell attachment and survival ......................................................... 91
4.2.3.3 Phenotype expression .................................................................. 91
4.2.3.4. Statistics ...................................................................................... 92
4.3 Results ...................................................................................................... 92
4.3.1 Characterization of PGDF electrospun fibers ...................................... 92
4.3.1.1 Fabrication of scaffolds with different fiber diameter ..................... 92
4.3.1.2 Electrospun fiber dissolvability ...................................................... 94
4.3.1.3 Fumaric acid release profile from electrospun fibers .................... 95
4.3.1.4 Raman spectroscopy .................................................................... 96
4.3.2 Effect of peptides immobilized fibers on cell viability ........................... 98
4.3.2.1 UV detection of peptides binding .................................................. 98
4.3.2.2 Cell viability within the scaffold ..................................................... 99
4.3.2.3 Cell differentiation on different fiber diameter and fiber
immobilized with peptides ....................................................................... 100
4.4 Discussion ............................................................................................... 103
CHAPTER 5 Conclusions and Future Work ..................................................... 106
LIST OF REFERENCES .................................................................................. 109
VITA……………………………………………………………………………………124

ix

LIST OF FIGURES
FIGURE

PAGE

Figure 2.1. Motor neuron differentiation and morphology of mouse embryonic
stem cells. .......................................................................................................... 39
Figure 2.2. Effects of RA introduction on mRNA expression, transcription
factors and viability. ............................................................................................ 43
Figure 2.3. NaB treatment induces neural stem cells differentiation of
embryonic stem cells .......................................................................................... 44
Figure 2.4 Continued presence of Genistein promotes motor neuron
generation. ......................................................................................................... 47
Figure 2.5. Different metabolites effects on day 9 .............................................. 48
Figure 2.6. Efficient generation of motor neurons by PUR ................................. 49
Figure 2.7. Electrophysiological analysis of motor neurons ................................ 53
Figure 3.1. Synthetic biodegradable elastomer, poly (glycerol-dodecanedioate).
........................................................................................................................... 61
Figure 3.2. Electrospinning setup including a syringe pump, a high voltage
power supply and a new designed collector. ...................................................... 64
Figure 3.3. Number and weight average molecular weight determinations of
PGD. ................................................................................................................... 71
Figure 3.4. Raman spectra of DDA, glycerol and PGD, respectively .................. 72
Figure 3.5. A newly designed collector for electrospinning. ............................... 74
Figure 3.6. SEM images and diameter distribution of electrospun PGD fibers
from (A) 30%, (B) 40%, and (C) 50% (w/w) polymeric solution .......................... 75
Figure 3.7. Raman spectra of PGD/BS fibers prior to and after electrospinning. 76
Figure 3.8. Surface morphology of the degraded PGD with gelatin fibers after
different time points. PGD with gelatin fibers after (A) 4 days; (B) 14 days and
(C) 28 days ......................................................................................................... 77
Figure 3.9. Cell adhesion on the PGD with gelatin fibers after 1 day culture.
HFF cells staining with Calcein AM reagents (bright green, arrows) on the
scaffold (A) and tissue culture dish (B). .............................................................. 78

x

Figure 3.10. Resazurin assay showing the cell viability on PGD with Gelatin
fibers and PGD without gelatin fibers after 1, 3, 5, and 8 days. Cells directly
cultured on the tissue culture dishes used as control. ........................................ 79
Figure 4.1. (A) Synthetic biodegradable elastomer, poly (glycerol
-dodecanedioate co-fumarate). (B) RGDC immobilization. ................................. 88
Figure 4.2. SEM images (A-D) and diameter distribution (E-H) of electrospun
PGDF fibers from (A,E) 30%, (B,F) 40%, and (C,G) 50% and (D,H) 60% (w/w)
polymeric solution. .............................................................................................. 94
Figure 4.3. Surface morphology of PGDF fibers on (A) Day 1, (B) Day 14, (C)
Day 32 and (D) Day 64. ...................................................................................... 95
Figure 4.4. Releasing profile of FA from PGDF electrospun fibers. .................... 96
Figure 4.5. Raman spectra of PGDF and PGD, respectively. ............................. 97
Figure 4.6. Concentration of double bonded FA in PGDF fiber with and
without presence of peptide groups. ................................................................... 99
Figure 4.7. (A) Resazurin assay showing the cell viability on PGDF and
peptides modified PGDF fibers on day 4, 6, 8, and 11. .................................... 100
Figure 4.8. Expression of neural lineage markers through real time-PCR. ....... 102

xi

ABBREVIATIONS AND ACRONYMS
ALS

Amyotrophic lateral sclerosis

AMPK

AMP-activated protein kinase

ALK5

Activin receptor-like kinase 5

BMP

Bone morphogenetic protein

BDNF

Brain-derived neurotrophic factor

BS

Basal solution

CNS

Central nerve system

CVA

Cerebrovascular accident

CS

Chondroitin sulfate

ChANS

Chondroitinase ABC

CHIR

CHIR99021

DDA

Dodecanedioic acid

DM

Dorsomorphin

DMEM

Dulbecco's Modified Eagle's Medium

DAPI

4’, 6’-diamidino-2-phenylindole

DAQ

Data acquisition

EC

Embryonal carcinoma

EGF

Epidermal growth factor

ECM

Extracellular matrix

ELSD

Evaporative Light Scattering Detector

FGF2

Fibroblast growth factor-2

FBS

Fetal bovine serum

xii

FA

Fumaric acid

GFP

Green fluorescent protein

GM

Growth medium

GDNF

Glial cell-derived neurotrophic factor

GAPDH Glyceraldehydes-3-phosphate dehydrogenase
GPC

Gel Permeation Chromatography

hESCs

Human embryonic stem cells

HDAC

Histone deacetylase

HPLC

High Performance Liquid Chromatography

HFF

Human foreskin fibroblasts

IPSCs

Induced pluripotent stem cells

LIF

Leukemia inhibitory factor

MiRNA

microRNA

mESCs Mouse embryonic stem cells
mTG

microbial transglutaminase

mTOR

Mammalian target of rapamycin

MW

Molecular weight

NSCs

Neural stem cells

NPCs

Neural progenitor cells

NT-3

Neurotrophin-3

NIM

Neural induction medium

NaF

Sodium Fumarate

NaB

Sodium Butyrate

xiii

PNS

Peripheral nerve system

PLA

Poly (lactic acid)

PGA

Poly (glycolic acid)

PGD

Poly (glycerol-dodecanedioate)

PGS

Poly (glycerol sebacate)

PMMA

Poly (methyl methacrylate)

PEO

Polyethylene oxide

PVA

Poly (vinyl alcohol)

PLLA

Poly (L-lactic acid)

PCL

Poly (ε-caprolactone)

PLGA

Poly (D,L-lactic acid- co- glycolic acid)

PANI

Polyaniline

PPy

Polypyrrole

PGDF

Poly (glycerol dodecanedioate co-fumarate)

PLCL

Poly (L-lactic acid)-co-poly (e-caprolactone)

PUR

Purmorphamine

PCR

Polymerase Chain Reaction

PBS

Phosphate buffered saline

RA

Retinoic acid

RGD

Arginyl-glycyl-aspartic

SCNT

Somatic Cell Nuclear Transfer

SHH

Sonic hedgehog

SMA

Spinal muscular atrophy

xiv

SB

SB431542

SEC

Size Exclusion Chromatography

SEM

Scanning Electron Microscopy

TBI

Traumatic brain injury

TGF-β

Transforming growth factor-beta

TCA

Tricarboxylic acid

Tuj

β-Tubulin III

THF

Tetrahydrofuran

xv

CHAPTER 1 Introduction
1.1 Preface
1.1.1 Nerve Injury
The nervous system can be divided into two major sections: the central
nerve system (CNS), which consists of the brain and the spinal cord, and the
peripheral nerve system (PNS), which consists of the nerves that extend to the
rest of the body from the CNS [1]. The CNS injury is usually caused by a stroke,
a traumatic brain injury or developmental complications [2]. A stroke, also
referred to as cerebrovascular accident (CVA), is the loss of brain function due to
a disturbance (either ischemia or hemorrhage) in the blood supply to the brain [3].
Usually, it causes part of the brain to function improperly, leading to potentially
severe consequences such as vision impairment, aphasia, or inability to move
one or more limbs [4]. Traumatic brain injury (TBI) happens when the brain is
traumatically injured by an external force. It is a major cause of death and
disability worldwide, and it is usually caused by accidental falls, violence or
accidents [5]. In case of developmental complications, when CNS is not properly
developed resulting in abnormal tissue growth, the function of the CNS will be
highly affected, leading to neurological disorders [6]. The major cause of PNS
injury is trauma [1]. Fragile nerves can be damaged by stretching, pressure or
cutting, splitting the nerve into proximal and distal sections. When a nerve is
damaged by stretching or pressure, the nerve fibers break while the surrounding
tissues, which can be seen as an insulation, may remain intact. The proximal
section is still viable while the distal section dies. After a period, the damaged
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nerve may start the regeneration process. New nerve fibers may grow under the
surrounding tissue until they reach the sensory receptor or muscle. When a
nerve is cut, both the nerve and the surrounding tissues are severed. Without
proper medical treatment, the growing nerve fibers could form a painful nerve
scar, called neuroma. PNS injury interferes with signal transmission from the
body to the spinal cord and the brain, causing loss of muscle functions, and loss
of sensation in the injured area [7].
Numerous researchers are attempting to find an effective way to treat
nerve injuries. For CNS, spontaneous regeneration is quiet limited due to its own
inhibitory environment [1]. These inhibitions emerge from the formation of glial
scars and myelin-associated inhibitor factors. Therefore, researches are focusing
on how to promote the regeneration ability of neural tissues. Delivering
molecules such as morphogens, pharmaceutical drugs and microRNA (miRNA)
to the injury site is a possible method. Neurogenesis has been seen in some
animal studies but the benefits are limited due to the challenge of keeping the
molecules present at the injury site at a specific and constant concentration [6].
Another treatment option is stem cell therapy. Briefly, it is the culturing of stem
cells in vitro and then transferring these cells into the injury location. This method
has the benefit of preventing glial scar formation and promoting neurogenesis
originating from the patient, but also runs the risk of tumor development, low
survivability of the stem cells and stem cell migration out of the injury site [1]. As
for the PNS injuries, they are usually repaired by using either an autograft or an
allograft. While this treatment procedure frequently provides a superior neural
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functional recovery, it is also associated with significant drawbacks. For instance,
the size mismatch between the recipient and donor nerves, the functional loss at
the donor site, and the need of multiple surgeries are the common accompanying
drawbacks of autografts [8]. For allografts, patients are exposed to the risk of
immune/disease-related complications [8, 9]. It seems that no viable method to
effectively treat neural injuries exists. Researchers are looking for new strategies
to change the status-quo.
1.1.2 Neural tissue engineering
Tissue engineering has emerged as an excellent approach for
regeneration of damaged tissue, with the potential to circumvent the limitations of
current treatments [10]. Tissue engineering uses a combination of cells and
biomaterials (scaffolds) to repair, maintain, or improve tissue function. Neural
tissue engineering is a specific sub-field of tissue engineering. It is primarily a
search for strategies to develop effective neural guidance aimed at bridging gaps
in damaged peripheral or central neurons [1]. It delivers molecules to the injured
nerves by embedding the molecules into the biomaterials; improves the stem cell
survivability in vivo by supporting the cells growing at the injury sites; stops cells
from migrating out by holding them within the scaffolds. Also, it does not have the
side effects (size mismatch and function loss at the donor site) associate with
autografts and limits the risk of immune/disease-related complications associated
with allografts.
A critical element in successfully producing functional tissue in vitro is to
identify suitable biomaterials and use it to fabricate 3-D scaffolds that are
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conducive to cell attachment, proliferation, differentiation and ultimately new
tissue formation. Many methodologies have been developed to fabricate 3D
scaffolds using biopolymers over the past [11]. Recently, micro/nanofiber-based
scaffolds produced by using the electrospinning technique have been garnering
increasing interest, as it offers an opportunity to control over the composition of
the fibers, as well as over the porosity of the fiber meshes using a relatively
simple experimental setup [12]. In additional to its high porosity and large surface
area, a electrospun fiber scaffold provides a hierarchical structure highly
resemble the extracellular matrix (ECM), an environment critical for cell survival,
differentiation, signal transduction and nutrient/waste transport [13]. Moreover,
electrospun fibers can be modified with different physical or chemical methods to
encapsulate or attach bioactive molecules such as native ECM proteins to
support and guide both the survival and differentiation of cells seeded on the
scaffold. These attributes make electrospun nanofibers a new class of promising
scaffolds especially for neural tissue engineering.
The ultimate goal of this dissertation is to demonstrate that electrospun
fiber scaffolds made from PGD and its modified derivative are able to support
ESCs survival and differentiation into functional motor neurons using a newly
developed protocol. To achieve this goal, a new class of electrospun fiber
scaffold needs to be fabricated using a novel material poly (glyceroldodecanedioate) (PGD) and its derivative poly (glycerol dodecanedioate cofumarate) (PGDF). The performance of these fiber scaffolds needs to be
evaluated using human foreskin fibroblast cells and, more importantly, neural
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lineage cells derived from embryonic stem cells (ESCs). The outcomes of the
latter evaluation, if successful, will form a critical base for the development of an
improved strategy for treating peripheral nerve injury.
1.2 Background
1.2.1 Scaffold
As mentioned before, tissue engineering involves three important
elements: viable cells, biomolecules and a structural scaffold. The scaffold
serves as a foundation for the cells to grow and differentiate, and for the tissue to
form. Different subtypes of tissue engineering require different biomaterials for
tissue growing. Currently widely used biodegradable polymers such as poly
(lactic acid) (PLA) [14], poly (glycolic acid) (PGA) [15, 16] and their copolymers
are exceptionally stiff materials. For neural tissue engineering application,
biodegradable elastic materials are desired in order to better match the
mechanical properties of neural tissues. Therefore, a biodegradable polyester
elastomer called poly (glycerol-dodecanedioate) (PGD) was developed by
thermal condensation of glycerol and dodecanedioic acid (DDA) to meet this goal.
1.2.1.1 Poly (glycerol- dodecanedioate)
In the human body, cells efficiently build biological polymers from basic
units such as nucleotides, amino acids and monosaccharides with the help of
various enzymes. These nature polymers degrade back to original building units
and could be metabolized in what is called the recyclable process. To efficiently
produce a biocompatible and environmentally friendly polymer for tissue
engineering, it makes sense to model after the natural process by utilizing
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renewable and green starting materials with minimum waste generation, and
performing the reaction in a relatively efficient way without using toxic solvents,
hazardous chemicals and energy [17].
The recent surge of interest in thermally crosslinked elastomeric polymers
is largely due to the pioneering work of Robert Langer’s group, which in 2002
introduced poly (glycerol sebacate) (PGS), a polyester which is analogous to
vulcanized rubber [18]. Similar to PGS, Migneco et al successfully developed
poly (glycerol dodecanedioate) (PGD) by thermal condensation of glycerol and
dodecanedioic acid and demonstrated its unique shape memory property [19, 20].
PGD exhibits elastic properties similar to rubber and is biodegradable; therefore
it is very suitable for soft tissue engineering applications. Dodecanedioic acid is a
twelve-carbon

substance

with

two

terminal

carboxylic

groups,

HOOC

(CH2)10COOH. Even numbered dicarboxylic acids like sebacic acid and
dodecanedioic acid can be metabolized to acetyl-CoA and enter the tricarboxylic
acid (TCA) / (citric acid) cycle. Furthermore, the metabolic products of
dicarboxylic acids, succinyl-CoA, is a gluconeogenetic precursor and TCA cycle
intermediate [21]. Thus, some studies suggest that they could be utilized as
alternative fuel substrate for enteral and parenteral nutrition, especially in
pathological conditions. The most significant difference between sebacic and
dodecanedioic acids is that sebacic acid will be quickly excreted from the kidneys,
while dodecanedioic acid will not and is more suitable for the delivery of energy
in enteral and parenteral nutrition [22].
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Furthermore, PGD has one main characteristic that makes it unique
compared to PGS. The glass transition temperature of PGD is 32 ˚C, which is
above room temperature but below the physiological temperature. If PGD is
deformed below the Tg, the material will be able to keep its new dimension
resulting from the strain. However, if the elongation is induced above the Tg, the
material will immediately recover its original shape. As a consequence,
mechanical properties varied significantly based on temperature change. When
temperature is above the Tg (37 ˚C), PGD achieved a Young’s modulus, rupture
strain, and UTS of 1.08 MPa, 123% and 0.45 MPa, respectively. However, at
room temperature, PGD displayed a vastly different mechanical profile: a
Young’s modulus of 135.55 MPa, a rupture strain of 225%, and UTS of 0.45 MPa.
In addition to shape memory properties, PGD displays many beneficial
characteristics desirable for future in vivo biomaterial applications. In order to
understand the in vivo applicability of PGD, the in vitro degradation rates were
explored by Migneco et al in 2009 [19]. By soaking polyester samples in PBS at
37 ˚C for 20, 40, and 90 days, the mass loss due to hydrolysis was calculated. A
negligible change in mass was observed after 20 days; only 6% mass loss
occurred after 40 days. Over the course of the entire study (90 days), a total of
13% mass loss was noted. For tissue engineering applications, which need a
long time for natural tissue to populate on a PGD device, these results are
considered ideal. For other application such as drug delivery, the hydrolytic
lifetime of PGD can be shortened by varying the compositions and reaction
conditions
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As previously mentioned, glycerol is naturally occurring, with roles in lipid
biosynthesis, gluconeogenesis, and glycolysis. Dodecanedioic acid is also
endogenous to human metabolism, resulting from the ω-oxidation of lauric acid.
Cytotoxicity of PGD was therefore expected to be minimal, as these monomers
are compatible with biological systems. In order to explore this hypothesis,
human aortic fibroblasts (HAFs) were seeded on PGD-coated glass slides and
polystyrene plates [19]. The cell density on the polystyrene plates was higher
than that of cells on PGD-coated slides for approximately 18 days. However, at
that time point, the cell density on PGD surpassed the density of HAFs on
polystyrene. Cell viability and growth were monitored with the WST-1 assay.
HAFs were viable throughout the course of the study, with similar trends on PGD
and polystyrene [19].
1.2.1.2 Fabrication methods
When fabricating scaffolds for tissue engineering, three methods are
commonly used: phase separation, self-assembly and electrospinning [11].
Phase separation fabricates porous polymer membranes and scaffolds by
inducing the separation of a polymer solution into a polymer-rich phase and a
polymer-poor phase [23]. Self-assembly creates nanofibers that rely on weak
noncovalent interactions to build nanofibers from small molecules, nucleic acids,
proteins or peptides [24]. Electrospinning is time- and cost-efficient technique
that produces long, continuous fibers based on the electrostatic repulsion of a
polymer solution to form fibers [12]. Table 1.1 shows the advantages and
disadvantages of each method.
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Table 1.1 Three different scaffold fabrication methods and their
advantages/disadvantages.
Fabrication
Advantages
Disadvantages
methods
Phase
Good for creating porous scaffolds.
No organized pattern
separation
Simple, no special equipment
possible; limited
necessary. Porosity is easily
number of polymers.
controlled.
Self-assembly Molecules undergo spontaneous selfRequires engineering
assembly into higher order structures.
of molecules that will
self-assemble; can
only create short
fibers.
Electrospinning Can create aligned fibrous meshes.
Can only create fibers.
Can be used with biological polymers
such as collagen.

The main mechanism of phase separation, as the name suggests, is to
separate the phases due to their physical incompatibility. One of the phases,
which is the solvent, is then extracted, leaving behind the other remaining phases
[23]. It is simple and good for creating porous scaffolds, but pattern organization
cannot be controlled. For neural tissue engineering, organized patterns are
desirable, as they can better guide neural axon elongation. As to self-assembly,
the fabrication process is challenging, limited to a few polymers, and can only
create short fibers with lengths of one to several micrometer [24]. Comparing
these three methods, for neural tissue engineering, electrospinning where the
pattern can be controlled, and the fiber length can be adjusted to a few
centimeters, is an appropriate choice.
The basic principle of electrospinning involves a Taylor cone of solution,
which is held at the orifice of a needle by applying high voltage between the tip
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and the grounded collector. When the electrostatic repulsion in the solution
overcomes the surface tension, a charged fluid jet is ejected out of the needle tip,
traveling through the air with solvent evaporation, and finally deposited on the
grounded collector. The syringe pump provides a continuous flow of the solution
coming out of the spinneret and thus multiple copies of the electrospun fibers can
be fabricated within a short period of time. During the course of leaving the
spinneret and arriving at the collector, the charged jet undergoes stretching and
whipping according to a number of parameters, which are broadly classified into
solution parameters, process parameters and ambient parameters.
The solution parameters of electrospinning include molecular weight,
viscosity, concentration, conductivity, and surface tension. The molecular weight
of a polymer plays an important role in determining the size and morphology of
electrospun fibers. Generally, high molecular weight polymer solutions are more
widely used in electrospinning as they come with the desired viscosity for the
fiber fabrication. Studies have shown that a polymeric solution with low molecular
weight tends to form beads or beaded fibers rather than smooth fibers [25]. In
contrast, a solution with a high molecular weight would yield fibers with larger
average diameters. Gupta et al. have utilized PMMA with various molecular
weight to investigate the effect of molecular weight of a polymer on fiber
morphology. They found that as the molecular weight increases, the number of
beads decreases [26]. However, McKee et al. found that high molecular weight is
not always essential for electrospinning, as long as sufficient intermolecular
interactions can provide a substitute for the interchain connectivity obtained
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membranes
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phospholipids, for example, were produced from lecithin solutions via
electrospinning [27].
Viscosity of the electrospinning solution also has a significant effect on the
morphology and size of the electrospun fibers. No continuous fiber can form if
viscosity is too low. On the other hand, ejection of jets from a polymer solution
with high viscosity is very difficult. Therefore, an optimal solution viscosity has to
be determined in order to fabricate desirable fibers via electrospinning. Fong et
al. used polyethylene oxide (PEO) to investigate the effect of viscosity on fiber
production, and reported that viscosities ranging from 1 to 20 poise were suitable
for uniform nanofiber formation [28].
Polymer concentration is also critical to the production of fibers using the
electrospinning process. At a low polymer concentration, the process produces
beads, instead of fibers. As the concentration increases, the shape of the beads
changes from a spherical form to a spindle-like form and eventually the output
becomes uniform fibers. If the concentration is too high, the formation of
continuous fibers will be inhibited as it is impossible to maintain the flow of the
solution at the tip of the needle. It should be noted that molecular weight of
polymer, polymer concentration and viscosity are inter-related to each other. The
polymer concentration is strongly related to the viscosity and this relationship has
been studied with various polymers, including gelatin, poly (ethylene oxide)
(PEO), poly (vinyl alcohol) (PVA), poly (methylmethacrylate) (PMMA), poly (Llactic acid) (PLLA), etc. [26, 29-32]. Normally, increasing polymer concentration
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or viscosity gives rise to a larger or more uniform fiber size. In the electrospinning
process, polymer concentration plays an essential role in determining the range
of viscosities from which continuous electrospun fibers can be produced. Taken
together, previous studies show that there are optimal polymer concentration
values for electrospinning and that this property has a remarkable influence on
the morphology and diameters of polymeric fibers [33].
The conductivity of an electrospinning solution is typically determined by
the type of polymer, the solvent, and the availability of ionisable salts. Previous
studies show that there is a marked decrease in electrospun fiber size with the
increase of the solution’s electrical conductivity, and that with low conductivity,
uniform fibers are not produced and beads may also be observed due to the
insufficient elongation of the jet by electrical force [34]. Fibers with the smallest
diameter can be produced with the highest electrical conductivity polymer and
the decrease in the electrospun fiber diameter has been found to be due to
increased electrical conductivity [34]. The morphology and diameter of
electrospun fibers can be modified by adding ionic salts such as KH2PO4,
NaH2PO4, and NaCl, e.g. beadless fibers with smaller sizes ranging from 200 to
1000 nm were fabricated [35]. The same success has also been observed in
other polymer types such as polyamide-6 [36], PVA [37], polyacrylic acid [38],
PEO [28]. With addition of salts, the uniformity of electrospun fibers increases
and bead generation decreases.
Generally, reducing surface tension of the polymer solution leads to the
production of beadless fibers in an electrospinning process. Hohman et al. found
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that high surface tension inhibits the electrospinning process due to the instability
of the jets and the generation of sprayed droplets [39]. A lower solution surface
tension aids the electrospinning process in performing smoothly at lower electric
fields; however, a lower surface tension is not always suitable for electrospinning
[40]. The surface tension basically determines the lower and upper boundaries of
the electrospinning window when all other parameters are constant [28, 37, 41].
The processing parameters of electrospinning include the applied voltage,
the delivery rate, the distance from needle tip to collector and the collector types.
There is always a threshold voltage in the electrospinning process to ensure fiber
formation. When the applied voltage is above this threshold, a sufficient charge is
induced on the solution and the electrospinning process is initiated. There is a
dispute about the effect of the applied voltage on fiber diameter during
electrospinning. Demir et al. claimed that by applying higher voltages, more
polymer solution is ejected out of the needle and hence a larger diameter fiber is
formed [42]. Other researchers suggested that increasing the electrostatic
repulsive force by the increasing applied voltage will narrow the fiber diameters
because it forces greater stretching of the solution in the fluid jet [43-45]. Another
research group, Reneker and Chun reported there is no significant effect of the
applied voltage on fiber diameter with electrospinning of PEO [46]. Therefore, the
level of the applied voltage may influence fiber diameter, but its effect is
modulated by other parameters such as polymer concentration, solution viscosity,
and the tip-collector distance.
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In the electrospinning process, a lower delivery rate is always desirable,
as it leads to more time for solvent evaporation. However a minimum delivery
rate of the spinning still has to be maintained in order to produce continuous
fibers. Electrospun fiber diameter and pore size (determined by fiber diameter)
increase as polymer solution delivery rate increases. If the delivery rate is too
high, beads tend to form due to the lack of sufficient evaporation time prior to
reaching the collector [47-50].
One crucial element of the electrospinning process is the collector type. It
serves as the conductive substrate where the electrospun fibers are deposited.
Nowadays, many types of collectors, such as rotating mandrel, are used in the
electrospinning process [51-56].
Another parameter to control fiber morphology and diameter is the
distance between the needle tip and the collector; a minimum distance is
required to provide sufficient time for solvent evaporation and produce fibers. It is
also observed that a short distance between the needle tip and the collector
leads to the formation of flat, instead of round, fibers [43]. However, the effect of
this distance on the fiber size and morphology is not as strong as other
parameters.
In addition to the solution and the processing parameters, ambient
parameters such as humidity and temperature also affect the output of an
electrospinning process. Casper et al investigated the effects of humidity on
producing polystyrene fibers via electrospinning, and found that increasing the
humidity resulted in the appearance of small circular pores on the fiber mat and
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further increase in humidity caused the pores to coalesce [57]. At very high
humidity, the discharge of electrospun fibers is promoted. While at very low
humidity, the solvent may dry too fast, and the electrospinning process is
inhibited [58, 59]. The effect of ambient temperature on electrospinning
polyamide-6 has been studied by Mit-uppatham et al and the results suggest that
an increase in the temperature leads to a decrease in fiber diameter. Studies
also found that there is an inverse relationship between the temperature and
polymer solution viscosity [36].
Electrospinning constitutes a unique technique for the fabrication of micro
to nanometer fibers. The advantages associated with fiber scaffolds fabricated by
electrospinning include time- and cost- efficiency, high aspect ratio, high specific
surface area, and high porosity with a small pore size [12, 60, 61]. A variety of
natural and synthetic materials such as gelatin [62], collagen [25], poly(εcaprolactone) (PCL) [41], poly (D,L-lactic acid- co- glycolic acid) (PLGA) [15, 16],
and PLLA [14] fibers have been successfully produced using the electrospinning
process. These electrospun fibers will play a significant role in different tissue
engineering areas and typical examples of which include neural, bone, cartilage,
skin, tendon and ligament and cardiovascular tissue engineering [63-68].
1.2.2 Stem cells and its differentiated neurons
In the neural system, neuron or glial cell degeneration could lead to
various clinical disorders. Nerve injury is a daunting challenge because most of
these injuries result in irreversible loss of function. Therefore, another key
element of neural tissue engineering is employing normal or genetically
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engineered cells to repair injured locations. Different types of cells such as
embryonic stem cells, induced pluripotent stem cells and neural stem cells have
already been studied by researchers.
1.2.2.1 Teratomas, pluripotent stem cells, and mouse embryonic stem cells
Teratomas, a rare clinical tumor, is the beginning of the whole pluripotency
story. It carried all three germ layers: ectoderm, mesoderm and endoderm,
similar to what is found in a developing embryo [69]. Thanks to Stevens study [70]
on spontaneous testicular teratomas and later the work of Kleinsmith [71] and
Pierce on teratocarcinoma, the embryonal carcinoma (EC) cell lines were
developed and the mouse embryonic stem cells (mESCs) were finally
established from the inner cell mass of mouse blastocysts in 1981 by two
different groups[72, 73]. Initially, mESCs were cultured in conditioned medium of
teratocarcinoma and feeder layer cells. Later on, Leukemia Inhibitory Factor (LIF)
was identified and purified for maintaining the pluripotency of mESCs [74]. From
then on, mESCs routinely maintained in labs became the working horse to help
explore the unknown stem cell and developmental biology.
1.2.2.2 Human embryonic stem cells
Although the use of human EC cell lines in research dates back to 1970’s
[75], the equivalent human embryonic stem cells (hESCs) was not established
until 1998 by Thomson et al. [76]. The explanation of this technical delay in
hESCs could be due to the different requirements of maintaining hESCs. Unlike
the mESCs whose self-renewal is dependent on the LIF activated STAT3
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signaling pathway [77], undifferentiated hESCs are maintained in the presence of
mouse embryonic fibroblast feeders [76]. For the sake of maintaining hESCs in a
feeder-free condition, condition medium from feeder cells plus Fibroblast growth
factor-2 (FGF2) [78], high concentration FGF2 [79], or Transforming growth
factor-beta (TGF-β), Nodal and Activin A [80, 81] had been used for supporting
undifferentiated culture on Matrigel or other ECM coating plates.
Furthermore, there are several differences between mouse and human
embryonic stem cells, such as colony morphology and surface markers (SSEA1
vs. SSEA3), even though they both share the same core regulatory transcription
factors like Oct4, Sox2 and Nanog for pluripotency. Recent studies indicated that
mouse and human embryonic stem cells may represent different developmental
stages of pluripotent stem cells. Especially hESCs are more similar to mouse
epiblast stem cells in terms of morphology, growth requirement and gene
expression profiles [67, 82].
Since the successful culturing of hESCs, those cells attracted the attention
of the scientific community to explore their potential clinical applications based on
investigating basic stem cell biology. The unique self-renewal and pluripotent
properties of hESCs provide an unlimited cell source for tissue engineering and
regenerative medicine.
To date, the utilization of human embryos to create hESCs lines still
presents ethical and political concerns, resulting in fervent debate regarding this
area of research. Another concern for ES cell transplantation is the genetic
differences between the ES cells and the patient; immunosuppression drugs may
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be required to prevent rejection [83]. In order to develop patient- specific
pluripotent stem cell, an alternative strategy called Somatic Cell Nuclear Transfer
(SCNT), based on the early discovery of Goudorn’s study by replacing an
oocyte’s nucleus with another somatic cell’s nucleus [84], had been proposed
and demonstrated in mammals [85-87]. But this approach also faces the same
ethical considerations for using human oocytes and destroying resulted embryos
as well as technical challenges [88].
1.2.2.3 Induced pluripotent stem cells
A recent exciting development of mouse induced pluripotent stem cells
(iPSCs) by Takahashi et al. [89] opened a new road for converting somatic cells
to pluripotent stem cells. They carefully screened two dozens transcription
factors that are highly expressed in ES cells and finally narrowed down to four
key factors that are sufficient for reprogramming. By transducing four
transcription factors (Oct4, Sox2, Klf4, and c-myc), also called ‘‘Yamanaka
factors’’, into mouse embryonic or adult fibroblasts, these reprogrammed somatic
cells exhibited mouse embryonic stem (ES) cell-like properties in terms of
morphology, growth properties and gene expression patterns. In addition, they
can form teratomas after injection into mice. After a few months, Wernig et al. [90]
reached the same conclusion for mouse iPSCs with ES-like properties, and
further showed that mouse iPSCs could form chimaeras as well as generate
functional germ cells.
In less than a year, Yamanaka’s group [91] demonstrated again that the
same four transcription factors could be used to obtain human iPSCs.
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Immediately, other groups confirmed this somatic cellular reprogramming
feasibility [92-94] and demonstrated that other defined factors (Oct4, Sox2,
Nanog, and LIN28) also worked [92]. It was concluded that human iPSCs and
human embryonic stem (ES) cells are similar in regards to their morphology,
growth, surface antigens, gene expression, and telomerase activity. Furthermore,
these cells could differentiate into cell types of the three germ layers in vitro and
form teratomas in vivo.
Even though the efficiency of reprogramming iPSCs is still low and it
exhibits some safety concerns of using viruses for delivery of exogenous genes
and having the potential to form teratomas from undifferentiated cells, this
technique still attracts a lot of scientific interest. Due to the simplicity and
repeatability of iPSCs technology, multiple somatic cells and species have been
tested and validated. The advancement of this technique resulted in explosive
research activities in the past few years and is expected to accelerate the
development of the use of iPSCs from patients for therapeutic purpose. One of
the biggest advantage of using iPSCs is that the original source cells can be
derived directly from patients.
1.2.2.4 Neural stem cells, neurons and glial cells
Due to limited access to human neural tissues, direct harvest of
differentiated neural cell or adult neural stem cells is not always a viable choice.
The characteristic properties of pluripotent stem cells are the capability of selfrenewal and differentiation into any cell type of three germ layers. Since the
establishment of hESCs, a great deal of research have been made to explore the
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potential of differentiating hESCs to clinically relevant cell population such as
dopaminergic neurons for Parkinson’s diseases and motor neurons and/or
oligodendrocytes for spinal cord injuries.
Interesting observations of the pluripotent stem cell differentiation process
seemed to recapitulate the major events in the embryo development. Thus
carefully following the sequences of embryo development and providing the right
combination of spatial and temporal signals normally led to specific lineage cells
[95]. For the differentiation of pluripotent stem cells to neuroectoderm lineages,
some studies have used conditioned media from stromal cells [96, 97], or
induced the formation of 3D embryoid bodies. The early study results had
indicated that in the absence of BMP signals, pluripotent stem cells would
differentiate into neuroectoderm lineage in default [98]. Therefore, a chemicallydefined medium will help scientists identify the mechanisms with less
interferences and accelerate the potential clinical application [99].
Multipotent neural stem cells (NSCs) or neural progenitor cells (NPCs) are
capable to differentiate into three major cell types: neurons, astrocytes, and
oligodendrocytes. For research purposes or clinical applications, more specific
subtypes of neurons and glial cells might be needed. For example, Wichterle et
al induced the differentiation of motor neurons from ES cells derived NSCs by
using retinoic acid and sonic hedgehog (SHH) analog [100]. Another clinically
relevant dopamine neurons for Parkinson’s disease had been shown to
differentiate from mouse [101] and human [102, 103] ES-cell derived NPCs in the
presence of FGF-8 and SHH. In addition, Nistor et al. [104] demonstrated the
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step-wise differentiation procedures for producing oligodendrocytes from human
ES-cell derived oligodendrocyte progenitors.
1.2.2.5 Motor neuron
Motor neurons originate in the motor region of the cerebral cortex, have
cell bodies in the spinal cord and axons that either directly or indirectly extend to
control muscles. It is clear that these cells have the potential to be very long,
especially when providing impulses to muscles in distal regions.
vertebrates,

motor

neurons

are

cholinergic,

thus

releasing

In all

only

the

neurotransmitter acetylcholine, and a single motor neuron has the potential to
innervate numerous muscles simultaneously. In vertebrates, motor neurons can
only provide an excitatory, contractile signal, and thus relaxation can only occur
by inhibiting the motor neuron itself.
Motor neuron diseases are characterized as primarily affecting either the
upper motor neurons or lower motor neurons [105]. Most often, motor neuron
disease has a genetic origin, with the primary associated diseases being
amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA) and
bulbospinal muscular atrophy. While in recent years there has been significant
progress in identification, classification and pathogenesis of motor neuron
diseases, there are still no available treatments for patients suffering from these
degenerative pathologies.

Direct implantation of motor neurons derived from

embryonic lines or induced pluripotent lines is still in the realm of science fiction,
although the protocols are slowly improving.

Alternatively, deriving a

pharmacological solution will require extensive testing on cultured motor neurons
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or animal models.

This pharmacological, cell-based approach is far more

clinically relevant at this time [106].
Current neural induction protocols typically require protein introduction,
conditioned media, feeder layers or SMAD signaling inhibition. Each of these
techniques has a significant drawback, such as poorly defined culture conditions,
elongated time-course or low yield.
The most typical motor neuron differentiation protocol requires the
introduction of a protein called Sonic Hedgehog (SHH) in the presence of
Retinoic Acid (RA). The starting step of this protocol requires the creation of
neuroepithelial cells from either ESCs or iPSC lines [107-109].

These

neuroepithelial cells form tube-like rosettes in human cell lines over the first two
weeks of culturing. In mouse lines, these rosettes do not form. The addition of
SHH in the presence of RA induces the cells to form motor neuron progenitors
which express OLIG2. It has been recently found that the protein SHH can be
replaced with the far less expensive small molecule PUR, with similar effects
[110].

One week later, these progenitor cells develop into immature, HB9-

expressing motor neurons. After another three to five weeks, functional mature
human motor neurons can be identified.
Instead of using this protein induction approach, the use of conditioned
media has been identified as a viable alternative.

With this approach, it is

necessary to culture the embryoid bodies in a conditioned media derived from
the human hepatocarcinoma cell line HepG2 (Medll) [111]. Using this conditioned
media at the embryoid body stage, neural precursors quickly emerged. While
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this approach is more complicated than the protein induction approach, due to
the need for conditioned media from a carcinoma cell line, it demonstrates the
novel possibility of using media conditioning as a technique for neural induction.
Unfortunately, this technique does not currently allow the specification of the type
of neuron derived unlike the more targeted protein induction approach.
Combining the approaches of protein induction and cellular conditioning
forms the stromal feeder approach. In this approach, embryoid bodies are first
cultured on MS5 stromal feeders [112]. These feeder layers promote a quick and
efficient generation of neural precursors, which following the introduction of SHH
and RA creates spinal motor neurons. The feeder layer approach has been
proven to be effective in generating not only neural cells but also a wide range of
glial cells. While it is slightly quicker than the protein induction method on its own,
its cost is significantly higher.
The final technique for discussion is the use of SMAD signaling inhibition.
SMAD signaling plays a tremendous role during neural induction and recent
studies have shown that particular elements of this signaling cascade, such as
bone morphogenic protein (BMP) inhibitors, are critical during the neural
organization phase of embryonic development [113].

This particular protocol

utilizes the same steps as the protein induction explanation above, but also adds
two additional molecules – inhibitors of SMAD signaling called Noggin and
SB431542. This protocol has been demonstrated to be robust and effective, as it
generated a complete neural conversion of over 80% of human ESCs in
adherent culture conditions.

23

1.3 Current research of cellular interactions on electrospun scaffolds for neural
tissue engineering
Central or peripheral nerve injury which cannot be directly repaired by
end-to-end sutures is still a daunting challenge in clinical research. Nerve
autograft transfers are the current gold standard for treating large nerve gaps but
limited by shortage of donor nerve, donor site morbidity and inadequate
functional recovery. A potential regenerative strategy is stem cell transplantation;
however, less than 1% cell survivability is far from the minimal requirement [9,
114]. To improve cell viability, stem cells can be transported via an artificial
scaffold, which provides an environment conducive to survival after delivery.
Electrospun nanofibers are well suited for this application as they can not only
promote the neural cell differentiation but also enhance the axonal elongation.
Neural cell proliferation and differentiation were shown to be affected by
several properties of nanofiber scaffolds. Yang et al. studied the influence of fiber
alignment on the differentiation of neural stem cells (NSCs) [14]. They fabricated
aligned nanofibers by using a rotating disc as a collector. The results
demonstrated that NSCs elongated and their neuritis outgrew along the
orientated nanofibers. In another study, Xie et al. reported that aligned PCL
nanofibers not only enhanced the differentiation of embryonic stem cells into
neural lineage cells but also controlled the direction of neurite extension [115]. In
addition, the diameter of fibers has been shown to affect NSCs differentiation and
proliferation. Christopherson et al. claimed that as the diameter of fiber
decreased, the NSCs showed more migration, spreading and proliferation [63].
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Furthermore, it was observed that the NSCs showed an increased rate of
differentiation and proliferation on oriented nanofibers compared with microfibers
[14].
Some recent studies have proved that the conductivity of nanofibers can
also influence the neural cell behavior. Ghasemi-Mobarakeh et al. obtained
conductive electrospun nanofibers by mixing polyaniline (PANI) with poly (ε caprolactone)/ gelatin (PG). Electrical stimulation through 15%PANI/85%PG
nanofibrous scaffolds showed enhanced NSCs proliferation and neurite
outgrowth [116]. Cullen et al. fabricated nanofibers consisting of a blend of PANI
and polypropylene as living neural-electrical relays. This fiber scaffold shows the
potential to promote primary dorsal root ganglion neurons adhesion, growth and
neurite extension [117]. In another work, Liu et al. used Polypyrrole (PPy)
substrates doped with chondroitin sulfate (CS) and conjugated with type I
collagen. The collagen could self-assemble into 3-dimensional fibrillar matrix at
the polymer surface. Their results showed that rat pheochromocytoma cells had
an increased differentiation rate on the polymer substrates and electrical
stimulation promoted the neurite outgrowth [118].
Other research groups have worked on incorporating proteins onto
electrospun nanofiber scaffolds. Liu et al. investigated the feasibility of loading
chondroitinase ABC (ChANS) and neurotrophin-3(NT-3) onto electrospun
collagen nanofibers [119]. By using microbial transglutaminase (mTG) mediated
crosslinking, the protein incorporating efficiency could reach 45-48%. Their
results demonstrated that sustained release of NT-3 and ChABC through
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collagen nanofibers can promote axonal regeneration and thus could be useful in
spinal cord injuries treatment. Further, another research group immobilized EGF
and bFGF onto PLLA nanofiber scaffolds and found significant enhancement of
the axon growth [120].

Lee et al. coated PLGA nanofibers with PPy and

immobilized nerve growth factor (NGF) on to the surface. These NGFimmobilized PPy-coated PLGA scaffolds showed the supportive of PC12 neurite
formation and outgrowth [121].
1.4 Research Plan
The objective of this study is that electrospun fiber scaffolds made from
PGD and its modified derivative are able to support ESCs proliferation and
differentiation into functional motor neurons using the newly developed protocol.
To complete the objective of this PhD research, several experimental
studies (specific aim 1, 2 and 3) were designed and sequentially carried out.
These studies reflect the progression of the development this PhD research, and
hence become the frame work of this dissertation.
In Chapter 2 of this dissertation (Specific aim 1), the development of an
efficient and economical approach to direct the differentiation of ESCs to motor
neurons is presented. The reason behind this development is that a large
number of motor neurons is required to carry out a research project that aims to
develop a new therapy for nerve injuries (i.e., the scope of this PhD research).
Primary culture of motor neurons is not a feasible option here because the
survival and proliferation of primary motor neurons tend to limited in an in vitro
environment.
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The use of ESCs is considered because they could, potentially, proliferate
unlimitedly and can be derived into neurons as well as other neural cell types
using different protocols. To successfully realize this idea, a small-molecule
based methodology to differentiate ESCs into defined neural lineages in a fully
controlled and efficient manner was developed. This protocol was tested with
ESCs on the culture dishes as well as the electrospun fibers.
In Chapter 3 (Specific aim 2), the focus will shift to scaffold building.
Electrospinning is employed in this PhD research to fabricate fibers from polymer
PGD, a new class of biodegradable and biocompatible polymers developed by
Migneco et al in 2009 [19], and its gelatin blended long fibers. The morphology,
chemical structure, dissolvability and biocompatibility of the electrospun fibers as
well as the effects of fabrication parameters on these characteristics are reported
in this chapter.
However, one disadvantage of the PGD polymer is that it is composed of
saturated polyester chains that only have hydroxyl or carboxylic groups available
for chemical modification. If another double-bond containing monomer is
introduced, the resulting polymers with unsaturated polyester chains may provide
new modification possibilities. These properties, in turn, can be used to modify
PGD fibers and facilitate cell attachments. For this reason, fumaric acid, a nontoxic, naturally occurring monomer, was incorporated into the PGD polymer
synthesis process and produced a PGD derivative referred as poly (glycerol
dodecanedioate co-fumarate) (PGDF) (Specific aim 3). It was combined with
gelatin and PEO to fabricate electrospun fiber scaffolds. Both PGD and PGDF
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based scaffolds were then used in a study of the growth and morphology of
neural lineage cells to determine the effects of newly fabricated scaffolds on cell
proliferation and differentiation. The results of this study are presented in Chapter
4 of this dissertation.
In the final chapter of this dissertation, a summary of the scientific findings
of this Ph.D. research is provided, which supports the research hypothesis and
demonstrates the success of this research project. In addition, a critical
evaluation of the potential of this research project as well as a list of future work
required to realize the ultimate goal of this research (i.e., developing a new
therapy for nerve injuries) will be provided.
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CHAPTER 2 Efficient and Low-Cost Differentiation of Embryonic Stem Cells into
Motor Neurons by Metabolites for Neural Tissue Engineering
2.1 Introduction
As mentioned in chapter 1, efficient cell differentiation protocol is one of
the important factors for neural tissue engineering. Other than the typical
protocols for neuron differentiation mentioned previously, small molecule
techniques have emerged in recent years to provide an inexpensive means of
differentiating pluripotent or embryonic lines into motor neurons. This is
accomplished most often by inhibiting or stimulating particular pathways that
guide the differentiating cells into their final desired form. Small molecules that
have been used so far in recent literature in the generation of neurons include
Dorsomorphin (DM), SB431542 (SB), CHIR99021 (CHIR), and Purmorphamine
(PUR) [122].
DM is an inhibitor of AMP-activated protein kinase (AMPK) and BMP
signaling. It is believed that DM assists neural induction by inhibiting BMP Type1 receptors ALK2, ALK3 and ALK6 [123]. In addition to the BMP-inhibition of DM,
it has been recognized that SB must also be added due to its effect of inhibiting
TGF-β. SB has been shown to specifically inhibit TGF-β type 1 receptors, also
known as activin receptor-like kinase 5 (ALK5) [124] while having no effect on
BMP signaling.

The combination of these two small molecules allows initial

neural induction.
Neural induction is also maintained by inhibition of the Wnt- β pathway,
carried out by using the small molecule CHIR. The Wnt- β pathway has been
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implicated in neural crest induction but only recently has it been demonstrated
that by inhibiting the pathway the ectoderm is able to expand the size of the
neural plate [125]. When upregulated during this developmental phase, neural
plate formation is not properly induced. Thus, it is clear that this pathway is
another potential target for low-cost neural induction.
The final small molecule for discussion is PUR, which is currently used in
recent literature (as well as in this particular study) as a replacement for the more
expensive SHH. SHH is a well-studied morphogen and has been shown to
contribute to floor-plate development within the neural tube. Specifically, SHH
has been shown to induce the differentiation of motor neurons and ventral
interneurons [126]. Fortunately, PUR fulfills all of these same functions, and thus
the addition of PUR is a crucial step when inducing neural cells towards a motor
neuron lineage [110].
While the previously described small-molecule techniques improve
induction and differentiation efficiency, the metabolite techniques utilized in this
study were mostly used to improve survival. Specifically, Sodium Fumarate (NaF)
and Genistein were applied to reduce oxidative stress and Sodium Butyrate
(NaB), a histone deacetylase (HDAC) inhibitor, to promote neural cell
differentiation. The use of these metabolites was both individually and collectively
tested.
NaF

has

been

demonstrated

to

be

both

neuroprotective

and

cardioprotective through activation of the Nrf2 antioxidant pathway [127, 128].
NaF is derived from Fumaric Acid, which is a metabolite and intermediate
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product of the citric acid cycle [129].

Time-dependent and concentration-

dependent studies have been carried out that demonstrate NaF to be
immunomodulatory and able to reduce oxidative stress without altering
fundamental network activity [127, 128]. In vitro, its addition has been shown to
improve neuronal survival. In vivo, NaF works to better preserve the integrity of
myelin, axons and neurons [129].

The choice to add it to this experimental

protocol was due to a fundamental belief that its preservative ability would impact
cell survival and induction efficiency.
Genistein was chosen for a very similar reason, the reduction of oxidative
stress, although it also aids in neural induction. Genistein is an isoflavone, a
small molecule that has estrogen-like activity, and is believed to be useful as a
preventative agent for hormone-related cancers [130]. Genistein is a secondary
metabolite originating from plants, although its specific mechanism of action is
unknown. It is also an inhibitor for protein phosphorylation at tyrosine residues, a
process that researchers believe is responsible for neural differentiation [131]. In
addition to its inductive ability, it has been proven to aid in neuronal cell viability
and proliferation in vitro [132].

Genistein’s ability to modulate and reduce

mitochondrial oxidative stress reduces neural apoptosis, even further supporting
survival [133]. Similarly to NaF, Genistein was tested in this protocol due to its
inductive and protective abilities.
NaB was chosen for this study due to its role as an HDAC inhibitor and a
metabolite. HDACs have been experimentally demonstrated to compact
chromatin and silence genes, and are implicated in numerous dysfunctional
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neuronal conditions, such as depression, addiction and memory problems [134]
[26]. This same study examined the effects of inhibitions of different HDACs on
mouse embryonic neurogenesis and demonstrated that the inhibition of HDACs
by NaB inhibit BMP signaling and promote neurogenesis.

Thus, NaB acts

similarly to the small molecule Dorsomorphin, referenced above.

NaB is a

metabolite, however, and thus is more useful for controlling which metabolic
pathways are activated. While NaB has been studied generally in neurons, it has
not been studied specifically concerning its impact on the survival and
differentiation of motor neurons. HDAC inhibitors have also been demonstrated
to promote differentiation of embryonic stem cells into neural cells in adherent
monoculture, but in a surprising reversal, they have also been demonstrated to
assist lineage-committed oligodendrocyte precursor cells in converting into
multipotent cells akin to neural stem cells [135, 136]. Due to its aid in inducting
embryonic stem cells into neural lines, NaB was utilized in this study.
These metabolites were essential to the study because of their roles as
metabolites. Each of the three just mentioned, as well as RA, are important
intermediates or byproducts of metabolic mechanisms, and are thus important for
upregulating or downregulating particular metabolic pathways. RA is the active
metabolite of Vitamin A and a powerful regulator of gene transcription [137].
Vitamin A was chosen due to its effects on cell growth and immune function.
NaF, the intermediate of the tricarboxylic acid (TCA) and Kreb Cycle, was
selected since glycolytic metabolic mechanisms inhibit stem cell induction. While
NaB’s role as a metabolite is poorly understood, it has been demonstrated to
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regulate acetyl-CoA synthesis [138]. Genistein’s metabolism mechanism is also
not well documented, however its status as a metabolite is confirmed. While the
particular mechanisms by which these metabolites are used are poorly
understood, they all have been individually linked to the downregulation of
glycolysis and upregulation of oxidative phosphorylation that is typical to
induction mechanisms. By using metabolites instead of other typical small
molecules such as cytokines or growth factors, there is a potential to maximize
the effect on the cell’s metabolic pathway while simultaneously reducing the input
cost.
After indicating that each of these small molecules is a known metabolite,
now it is the time to demonstrate why metabolic pathway modulation is the key to
the motor neuron induction.

Stem cells are well known to have different

metabolic mechanisms and requirements than differentiated somatic cells. It is
believed that stem cells alternate between self-renewal and differentiation
through metabolic changes, modifying the mammalian target of rapamycin
(mTOR) and AMPK pathways [139]. Since DM is a well-known AMPK inhibitor,
metabolic modification may be a key component of its use in aiding neural
induction.

Accumulating evidence has suggested that metabolites may be

essential in modulating the cell signaling pathways and epigenetic regulation,
and through using them, it is able to stimulate specific metabolic pathways that
favor induction.
Through these modifications, stem cells begin to favor aerobic glycolysis
over oxidative phosphorylation.

ESCs specifically have a lower oxygen
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consumption rate, less mitochondrial membrane potential and a higher
concentration of glycolytic enzymes, thus favoring glycolysis [140]. The aerobic
glycolysis cycle is subject to substantial energy demands due to the shortened
cell cycle of the stem cells. In order to promote the stem cell differentiation, the
energy production pathway was shifted away from glycolysis by using Dulbecco's
Modified Eagle's Medium (DMEM) Low Glucose medium, which has been
validated in previous literature [108]. The additional metabolites also contributed
to the shift away from glycolysis. Following the discussion of the results of the
particular metabolite approach, potential metabolic mechanisms that aided motor
neuron induction strategy will be addressed and how each metabolite was used
to shift energy production towards oxidative phosphorylation will be proved. It is
believed that through understanding the metabolic underpinnings of stem cell
differentiation, novel metabolite approaches can be easily derived to provide lowcost approaches to stem cell differentiation.
In this chapter, highly efficient and cost-effective production of motor
neurons from mESCs through the application of metabolites (RA, Genistein, NaF,
and NaB) was examined. These metabolites have not collectively been tested
specifically with motor neurons until now and only RA has been used at all to
induce this cell type.
2.2 Experimental
2.2.1 Motor Neuron Induction from Mouse Embryonic Stem cells
Green fluorescent protein (GFP) -Expressing mESCs were purchased
from GlobalStem. The procedure for maintenance of mESCs was as follows: The
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mESCs were cultured on poly-L-lysine/laminin (Sigma-Aldrich, Fisher Scientific)
coated culture dishes in embryonic stem cell growth medium (GM, DMEM-High
glucose supplemented with 15% Fetal bovine serum (FBS), 10 ng/ml LIF, and
0.1 mM β-mercaptoethanol). Before neural induction, RA (1 μM, Sigma-Aldrich)
was added into the GM for 24 hours (Day0). On day1, cells were cultured in
neural induction medium (NIM, 1:1 mix of DMEM-Low glucose and F12
supplemented with B27 (Invitrogen), 1μM Genistein and 0.25mM Sodium
Butyrate (NaB) (All from Sigma-Aldrich) for 3 days. The medium was changed
every day.

On day4, 1μM RA, 5 ng/ml SHH (PeProTech), 200μM Sodium

fumarate (NaF) and 1μM Genistein were added for another 5 days for motor
neuron induction. On day 9, RA, NaF, Genistein and PUR/SHH were removed
from the medium and cells were cultured with 10 ng/ml brain-derived
neurotrophic factor (BDNF, PeProTech), 10 ng/ml glial cell-derived neurotrophic
factor (GDNF, PeProTech), and 0.5 mM Creatine (Sigma-Aldrich) for 2 days or
longer.
2.2.2 Functional evaluation of motor neuron differentiation
2.2.2.1 Reverse Transcription-Polymerase Chain Reaction
Total RNA was prepared from motor neuron differentiation cultures using
SV Total RNA Isolation System (Promega). Each mRNA preparation was reverse
transcribed into cDNA using olig(dT)15, as described by the manufacturer
(GoScript Reverse Transcription System, Promega). Real-time Polymerase
Chain Reaction (PCR) was performed on a Real Time PCR System (Applied
Biosystems). For amplification, the cycling parameters consist of 1 cycle at 95 ˚C
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for 2 min and 20 s, followed by 40 cycles of 95 ˚C for 3 s and 60 ˚C for 1 min.
The comparative CT method was utilized to calculate the relative expression of
each target gene, and each is normalized relative to the expression of
glyceraldehydes-3-phosphate dehydrogenase (GAPDH) mRNA.
2.2.2.2 Immunocytochemistry
Motor neurons were subcultured on laminin-coated 35 mm dishes and
fixed by using SafeFix (SafeFix™ II All-Purpose Fixative, Fisher HealthCare) at
room temperature for 15 min. Immunocytochemical staining was performed using
standard protocols and antibodies against MAP2(1:100; GeneTex), ChAT(1:50,
GeneTex) and HB9 (1:50, Santa Cruz). Antibodies against β-Tubulin3 (E7;
1:12.5), and Nestin (Rat-401; 1:5) were purchased from the Developmental
Studies Hybridoma Bank. As secondary antibodies, donkey anti-mouse IgG
(H+L), donkey anti-goat IgG-TR and goat F(ab)2 anti-rabbit IgG(H+L) (Southern
Biotech) were used against the primary antibodies. Nuclei were counterstained
with 4’, 6’-diamidino-2-phenylindole (DAPI, Sigma). Images were collected using
a fluorescence microscope equipped with phase contrast optics and camera
(Nikon).
2.2.2.3 Evaluation of cellular viability
Resazurin fluorescent dye (Sigma-Aldrich, St Louis, MO), which had been
shown to be identical to the commercial assay Alamar Blue, was used as an
index of cellular viability [141-144].

Briefly, 1:10 dilution of the reagent was

mixed with fresh medium and added to each cell plate. Background controls of 1
ml of medium plus 100 µl of the resazurin reagent were also performed. The

36

plates were placed in an incubator at 37 °C and 5% CO2 for 4 hours to allow the
cells to metabolize the resazurin. Then, 100 µl medium samples from different
cell plates were collected into a 96-well plate in triplicate. Thereafter, the 96-well
plate fluorescence reader was set to measure the fluorescence intensity of a 590
nm emission with an excitation wavelength of 530 nm. The same procedure was
repeated at different time points (day1, day3, day5, day7, day9 and day11). The
experiment was repeated three times and each individual group had three
separate samples.
2.2.2.4 Extracellular Electrophysiology
For recording electrophysiological properties, a 35 mm plastic dish
containing cultured motor neurons in growth medium was used.

Prior to

electrophysiology measurements, cells were kept at 37 °C in a 5% CO2 incubator.
The dish was quickly transferred to the stage of an inverted microscope for study.
Cells were recorded within a dish containing the differentiation media.

The

ground of the pre-amplifier was connected to the dish media and metal
microelectrodes were slowly lowered inside. The faraday cage was connected to
the ground of the oscilloscope, which was located outside the faraday cage.
To study the electrical characteristics of the motor neurons, extracellular
electrical stimulation was used to depolarize the neurons, after which they
generated action potentials typical of native tissue.

1 MΩ impedance metal

electrodes (Eppendorf) were used to depolarize small clusters of neurons in the
dish. These electrodes were connected to a preamplifier (A-M Systems) ,which
was in series connected into an AC/DC Differential Amplifier (A-M Systems
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Model 3000).

This amplifier has a gating feature, which allows the metal

electrodes to be capable of both recording/amplifying a signal or transmitting
electrical stimulation, depending on the voltage level of a trigger input. To control
the complex timing of the system, a Native Instruments Data acquisition (DAQ)
Board (Native Instruments M-Series) was used. Once the DAQ Board sets the
amplifier’s trigger into stimulus mode, it triggers a pulse stimulator (A-M Systems
Isolated Pulse Stimulator Model 2100) to send a depolarizing pulse through the
amplifier and electrodes into the dish. Immediately following the pulse, the DAQ
board sets the amplifier into recording mode and records a five-second signal at
50k Hz. All software to handle the timing was composed and executed in Matlab.
To depolarize the motor neurons, a pulse of length 0.2 ms was used. To
determine the proper voltage/current to depolarize the cells, a low current of 30
µA was used for stimulation and was raised in steps of 10 µA until a signal was
seen. The amplifier was kept at a constant bandwidth of 300 – 20k Hz and an
amplification of 1000. A notch filter at 60 Hz was used to eliminate line noise.
2.3 Results
2.3.1 Efficient motor neuron induction from embryonic stem cells
2.3.1.1 Schematic procedures of motor neuron differentiation
The procedure for motor neuron induction is schematically summarized in
Figure 2.1A. Immediately after plating the mESCs (Figure 2.1B), a 24-hour RA
treatment was applied. This novel strategy was adopted to promote the epithelialmesenchymal transition (Figure 2.1C). Following this treatment, a combination of
Noggin, Genistein and NaB was applied for 3 days to promote the establishment
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became flat. (E, F) Neural stem cells were cultured in the presence of RA and SHH for 2 days
and 5 days. (G) Two days of axon elongation promotion. Scale bars: (B-D) 100 µm; (E-G) 10 µm.

2.3.1.2 RA Increases the Cell Viability and Restricts ESCs into Neuronal Lineage
The novel use of RA for a 24-hour incubation step on day 0 provided
significant improvement in cell viability and transformational efficiency. Figure
2.2A showed that the application of RA treatment reduced the expression of the
essential pluripotency factors Oct4 and Sox2 compared to the control group. The
difference between the decrease of Oct4 and Sox2 indicated that the expression
balance of these two factors was disturbed, which broke the maintenance of the
mESCs pluripotent state and leaded cells down the neural ectodermal cell
lineage (Figure 2.2B). After RA treatment, the mESCs started to lose typical
colony morphology and the cells began to migrate away from the colony. The
Immunocytochemistry images in figure 2.2C clearly showed that the control
group has more Oct4+ and Sox2+ cells than the experimental group. However,
the high expression of pluripotent stem cell markers implied that most cells are
still not differentiated for day 0 RA treatment, but initiate the differentiation again
upon the second wave of RA treatment. Therefore, this result suggested more
RA treatment (also see the reference) for the low Pax6 expression is necessary.
By examining differentiation markers, upregulation of NE cell lineage was
confirmed (Figure 2.2D). Pax6 was expressed at comparable levels in RA and
control groups from day 1 to day 3, but between day 3 and 5, the control group
began expressing it at higher levels than the RA group. This trend reversed from
day 5 to day 7. When examining the expression of Nestin, it is clear that the RA
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group produced it significantly more from day 1 to day 5. After day 5, Nestin
expression grew exponentially, far faster than in the control group. This may
indicate that the use of RA on day 0 has its most profound impact on Nestin
expression only when the neural stem cells are differentiating into precursor
motor neurons.

MAP2 and DCX, both neural markers, demonstrated similar

trends in the quick growth of their expression levels in the RA group that far
outpaced the expression of the control group from day 1 to day 7. All four of
these markers are indicators of an ectoderm differentiation pathway and are thus
desired to grow in intensity to demonstrate neuronal lineage. T represents
mesoderm marker, which was never significantly expressed, indicating that the
pathway was never pursued. Endoderm marker Sox 17 was expressed higher in
RA group than control, indicating that RA may also promote endoderm
expression.
After examining the cell viability, as measured with Resazurin, every other
day for 11 days, it is clear that the RA treatment strongly promoted the survival of
the cells over the control group (Figure 2.2E). It is intriguing to recognize that the
only significant difference in cell viability between the experimental and control
groups happened on days 1, 7, 9, and 11. This data indicates that the cell
viability is not significantly different during the neural stem cell stage, but grows
to significance during the precursor motor neuron and mature motor neuron
stages. It could indicate that the cell is far more susceptible to apoptosis during
motor neuron induction, and thus the addition of RA on day 0 and later may have
a protective long-term effect for the experimental group.
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Figure 2.2. Effects of RA introduction on mRNA expression, transcription factors and viability.
Expression of pluripotency (A,B) and differentiation (D) Primers in mESCs were assessed by real
time-PCR. (A, D) The gene expression level were normalized to the house keeping gene GAPDH
expression level. (B) Normalized the gene expression level of RA treatment group on day 1 to
day 0. Average values and standard errors are from two replicate experiments. (C) RA
significantly decreased the protein expression of the pluripotency factors. (E) RA increases the
Cell Viability. Scale Bar: 100 µm. Sample number in each group, n=3. Average values and
standard errors are from three replicate experiments, *p<0.05

2.3.1.3 The Effect of NaB on the Conversion of ESCs into Neural Stem Cells.
The impact of NaB was examined using real time PCR and
Immunocytochemistry. After the fourth day of the protocol, the expected neural
stem cell marker Nestin and neural marker MAP2 were expressed 25% and 37%
higher than the controls, respectively (Figure 2.3A). The mesoderm marker T
was consistently expressed below control levels and the endoderm marker
Sox17 was expressed at the same levels as controls by day 4. Examining the
results of Immunocytochemistry on day 4 it is clear that the neural stem cell
marker Nestin is far more highly expressed in the NaB trials (Figure 2.3B).
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expressed on day 7 while motor neuron marker HB9 was drastically upregulated
on day 11 in metabolites group. ChAT, a mature motor neuron marker,
consistently displayed a significantly higher expression compared to the control
group, indicative of the fact that the use of this array of metabolites can quickly
create mature motor neurons.
Representative staining in metabolites and groups using antibodies
against MAP2, ChAT and HB9 are demonstrated in Figure 2.4B through
Immunocytochemistry. Examining the results of Immunocytochemistry, it is clear
that HB9 and ChAT are far more strongly expressed in the metabolites group
than in the control group. Ratios of HB9+ and ChAT+ cells are significantly
different between control and metabolites treated group (Figure 2.4C).
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Figure 2.4 Continued presence of Genistein and NaF promotes motor neuron generation.
(A) The expression of MN specific genes such as ISL1, Olig2, HB9, ChAT were upregulated by
the treatment of metabolites. The genes were shown as a fold change relative to the control
(equal to 1). (B) Immunocytochemistry images of MAP2, HB9 and ChAT positive cells in both
groups on day 11. Scale Bar: 10 µm. (C) Metabolites treatment greatly increased HB9+ and
ChAT+ cells. Average values and standard errors are from three replicate experiments, p<0.05

2.3.1.5 Effects of Various Combinations of Three Metabolites
While the previous results demonstrate the efficacies of Genistein, NaB
and NaF, additional tests were performed to determine the effects of any
interactions and the ideal combination, if one existed. Fundamentally, whether
particular combinations of these three metabolites would be ideal in maximizing
mature motor neuron differentiation efficiency and viability were studied.
To analyze the effects of specific combinations of the metabolites, the
expression of different markers including Olig1, GFAP, Olig2, ISL1, HB9 and
ChAT were measured (Figure 2.5). Olig1 and GFAP are Oligodendrocyte and
Astrocyte markers, respectively, and expression of them was undesired for the
purposes of this experiment. Surprisingly, the combination of Genistein and NaB
specifically generated a large quantity of GFAP expression. The most desired
expression marker was ChAT, which indicates a mature motor neuron. It is clear
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Figure 2.6. Efficient generation of motor neurons by PUR. (A) Quantitative real time PCR
analyses (day 12) indicated expression of motor neuron progenitor and motor neuron markers by
differentiated neural stem cells that were cultured with RA or PUR from day4. Values provided
are relative expression levels compared to control group values, which are normalized to 1 (B)
Immunocytochemistry images of PUR trial showed similar protein expression level of
neural/motor neuron markers. Average values and standard errors are from three replicate
experiments. Scale Bar: 10 µm

2.3.1.7 Functional Features of ESC derived Motor Neuron.
The presence of an action potential that mimics native neuron is one of
the clearest indications of the success of the culturing and cell-type derivation
strategy. Each action potential recorded occurred following the stimulus, after
which baseline voltage levels were reacquired and maintained. The resting
potential of each of these trials immediately prior to the action potential averaged
to -72.3 mV, almost a perfect mimic of the resting potential of native neuron (-70
mV). In addition, the depolarization/repolarization phase and hyperpolarization
phase both lasted approximately 1 millisecond apiece, akin to native nerve cells
[145].
While a typical neuronal action potential causes a depolarization to 30-50
mV, extracellular measurements typically record weaker signals due to the
dissipation of the strength of the generated electrical field as it travels through the
medium towards the microelectrode. Although the measurements were made
extremely close to the target neurons, the action potentials measured prior to
amplification were only about 1 mV. Fortunately, previous literature supports
these values, as a study of retinal ganglion cells in vitro generated recorded
potentials in the 1-2 mV range with a similar pulse stimulation setup [146]. While
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baseline (Phase 2). Once the signal has returned close enough to baseline, a neuronal action
potential can be seen (Phase 3). (C) Various recorded motor neuron action potentials are overlaid,
each from different neural cell clusters in different dishes, demonstrating the overall homogeneity
of mature motor neuron action potential properties. Stimulation occurs immediately prior to the
beginning of the displayed recordings. (D) A side by side comparison of a stimulation-based
recording of a control dish (mESCs) and experimental motor neuron dish (blue rectangle
indicates action potential) using the same parameters demonstrates the ways in which the media
and surrounding cells modulate the instrumentation’s return to baseline.

2.4 Discussion
Incorporating RA into the growth medium 24 hours before switching to
differentiation medium is a critical step for mouse motor neuron induction. During
ESCs division, one or both daughter cells maintain the stem cell phenotype, and
it is controlled by both intrinsic and extrinsic mechanisms. Stem cells divide either
symmetrically or asymmetrically. The growth medium provides different external
signals that will keep a balance between symmetrical and asymmetrical divisions
and maintain an appropriate numbers of stem cells. In other words, the
pluripotent circuitry is not an independent entity, but rather a regulatory system
which maintains ESCs and chooses which induction pathway to pursue.
Incorporating RA into the medium breaks this balance and forces more stem
cells towards ectoderm linage. In addition, comparing to mESCs, RA-treated
ESCs are less sensitive to the existence of growth factor. Therefore, when the
LIF is withdrawn from the medium, cells have a higher tolerance to the new
medium thus preventing them from apoptosis because of the environment
change.
The impact of NaB as a metabolite inductive factor was clearly
demonstrated by the upregulation of neural stem cell markers Nestin and neural
marker MAP2 as compared to controls that did not receive the NaB treatment
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(Figure 2.3A). While the mesoderm factor was significantly downregulated in
comparison to the expected ectoderm factors, the endoderm factor Sox17 was
maintained at similar levels in both the treatment and control group.

The

maintenance of endoderm factors in addition to ectoderm factors prior to motor
neuron differentiation likely has an evolutionary origin.

The germ layer, the

primary layer of cells which form during embryogenesis, produce three layers in
humans (ectoderm, endoderm, mesoderm), however in vertebrates without
bilateral symmetry only two layers (ectoderm and endoderm) are produced [146].
It is clear that evolutionarily the ectoderm and endoderm are more tightly related,
which likely causes the similarity in ectoderm and endoderm markers expression
levels during the initial induction period towards immature neurons.
While the use of Noggin is traditionally essential for neural tube
development or neural cell induction, the impacts of using Noggin alone versus
using it alongside the three metabolites were investigated here. Noggin is a nonmetabolite essential signaling molecule that promotes patterning during
embryonic development, and in the absence of BMP4 it will cause the patterning
of the neural tube.

This is why BMP inhibitors are essential in this study.

Examining the results of real time PCR, the most important marker of success is
the expression of ChAT, which indicates the presence of a mature motor neuron.
While using Noggin alone generated a 3-fold increase in the expression of ChAT
by day 7 over controls which did not receive Noggin, the addition of the three
metabolites generated an expression of ChAT that was almost 24 times as
strong as the control group (Figure 2.4). Another strong indicator of the success
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of this experiment was the expression of HB9, another motor neuron marker. By
the 11th day of the protocol, while the Noggin group only had twice the level of
expression as compared to controls, the combination of all three metabolites was
expressed almost 30 times as strongly. It is evident that the metabolite approach
is significantly quicker for obtaining mature motor neurons by examining the
interplay between the Olig2 expression, an immature motor neuron marker, and
ChAT, a mature motor neuron marker.

On day 7 of the experiment, the

expression of Olig2 was far higher expressed in the N group than in the N+ M
group, while at the same time the expression of ChAT was significantly greater in
the N+ M as compared to the N group. It is evident that the addition of these
metabolites to the Noggin improves the speed and efficiency by which these cells
are induced into motor neuron lineage.
While the efficacy of the metabolite approach has been demonstrated
through the previous experiments, whether there was any interplay within this
group of metabolites was considered to determine if there was a possibility that a
sub-combination of the three metabolites would be more efficient than using
them all. After carrying out real time PCR using various combinations, it became
clear that for the most highly desired marker, the mature motor neuron marker
ChAT, the combination of all three metabolites was significantly more expressed
than any sub-combinations or a control group that received no metabolites by
day 9. Examining the expression of the motor neuron progenitor, Olig2, there
was little difference in its expression as compared to controls.

Since this is

already day 9, this may be an indication that most of the immature motor neurons
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had already matured by this point. While the motor neuron marker ISL1 is not as
much of an indicator of maturity as ChAT, its expression was not significantly
different between the groups either.
One surprising result from this analysis was the unexpected upregulation
of GFAP, an astrocyte marker, when the specific combination of Genistein and
NaB was used. GFAP was expressed 4 times as much with this combination as
opposed to the combinations of Genistein and NaF or Genistein, NaB and NaF.
At first glance, this data seems to indicate that the combination of NaB and
Genistein plays a catalytic role in astrocytic induction, which can be suppressed
through the addition of NaF.

To examine the potential method of action, a

commercially available astrocyte differentiation media, Gibco Astrocyte Medium
(Gibco) was first examined.

A particular component of it added in catalytic

amounts is called sodium selenite.

Sodium selenite is used in astrocyte

differentiation media to protect the cells against oxidative stress, a process that
simultaneously aids in the induction process. Based on the fact that only the
combination of Genistein (oxidative stress reducer) and NaB (neural lineage
differentiation assistor) upregulate the GFAP marker, while NaF (another
oxidative stress reducer) inhibits the effect, it seems that the origin of these
results may lie in the mechanisms of action of NaF and Genistein. While NaF
works through activation of the Nrf2 antioxidant pathway, Genistein acts through
the inhibition of protein phosphorylation at tyrosine residues. While analysis of
the differences in mechanism of action between these two processes may hold
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promise in uncovering a metabolite approach to astrocytic induction, further
studies will be needed to investigate this.
Real time PCR was used to confirm analytically that there was any
difference between the expressions of cells cultured in PUR to those in SHH.
Examining four markers previously described, Olig2, ISL1, HB9 and ChAT, it
could be seen that there was an insignificant difference between groups in the
production of mature motor neurons, as measured using ChAT.

The only

significant difference between the groups was in the expression of the immature
motor neuron marker Olig2, but since the difference is minute and ChAT was
comparably

expressed

it

is

believed

that

these

molecules

are

truly

interchangeable.
While real time PCR and Immunocytochemistry are valuable molecular
techniques for characterizing differentiated cells, electrophysiology was essential
for demonstrating that the mature motor neurons could be electrically stimulated
and generate typical action potentials. Fortunately, the resting potential, peak
voltage and timescale of neuronal action potentials was all shown to mimic native
tissue.

With the addition of electrophysiological analysis, the mature motor

neurons have been demonstrated to mimic native tissue functionally, structurally
and molecularly.
By choosing metabolites that affect stem cell metabolism in known ways,
a highly effective protocol was derived. We have mentioned previously how NaF
acts as an antioxidant by stimulating the Nrf2 antioxidant pathway, but previous
literature has shown that the mechanism of this pathway involves the redirection
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of glucose and glutamine away from glycolytic pathways towards more anabolic
pathways [147]. Clearly, the actions of NaF induce the differentiation of motor
neurons from ESCs through this metabolic modification. The effects of Genistein
can also be shown to have a metabolic origin. Genistein is a phytoestrogen,
belonging to the category of isoflavones, which intrinsically have anthelmintic
activity that inhibit glycolysis enzymes [148]. Thus it is evident that an origin of
Genistein’s ability may lie in an underlying metabolic mechanism. To finalize the
claims, NaB modulates metabolism must be demonstrated as well. Fortunately,
NaB has been shown to modulate glutamine metabolism by decreasing cell’s
ability to oxidize glucose, shifting the metabolism away from glucose and towards
the oxidation of butyrate [149]. RA was also an essential component of this
study, and numerous studies have recognized that it induces a metabolic shift
from glycolysis towards oxidative phosphorylation [150]. Through these claims, it
is clear that the array of small metabolites not only has been proven to help with
cell induction and survival, but also share an underlying metabolic mechanism.
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CHAPTER 3 Development of Electrospun Fiber Scaffolds using Poly (glyceroldodecanedioate)/Gelatin Blended for Neural Tissue Engineering
3.1 Introduction
The definition of tissue engineering in simple terms is to fabricate a tissue
construct mimicking the structural and functional characteristics of native tissues
in an in vivo environment. One critical success factor of such an endeavor is to
fabricate a skeleton, also known as ‘scaffold’, to imitate the function of the native
extracellular matrix (ECM) [151]. ECM in native tissue interacts constantly with
cells through various mechanical and biochemical means [152]. Therefore, an
ideal scaffolds must meet several requirements that include biocompatibility,
mechanical stability, appropriate topography, and presenting proper chemical
signals.
Currently, there are three common methods for fabricating nanofiber
scaffolds:

phase separation, self-assembly, and electrospinning [11]. Among

these techniques, electrospinning is the most popular due to its versatility,
flexibility and cost efficiency [153, 154]. The electrospun fibrous scaffolds present
an array of characteristics found in native ECM including high aspect ratio, high
specific surface area, and high porosity with small pore size. To date, fibrous
biomaterials have been generated from collagen [25], gelatin [62], poly(εcaprolactone) (PCL) [41], poly(D,L-lactic acid- co- glycolic acid) (PLGA) [15, 16],
and poly(L-lactic acid) (PLLA) [14] using electrospinning. It is believed that
electrospun fibrous materials will play a critical role in several tissue engineering
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areas such as neural, bone, cartilage, skin, tendon, ligament and cardiovascular
tissue engineering [11].
Choosing a suitable material to fabricate tissue scaffolds is the first most
significant step for tissue engineering. Popular biodegradable polymers such as
poly (lactic acid) (PLA), poly (glycolic acid) (PGA) and their copolymers are
exceptionally

stiff

materials.

For

soft

tissue

engineering

application,

biodegradable elastic materials are desired in order to better match the
mechanical properties of soft tissues. Motivated by this need, a biodegradable
polyester elastomer poly (glycerol-dodecanedioate) (PGD) was developed by
thermal condensation of glycerol and dodecanedioic acid (DDA) (Figure 2.1) [19].
Both glycerol and dodecanedioic acid can be derived from biorenewable sources
[155, 156] and can be metabolized by human cells as energy sources [157, 158],
thus both monomers exhibit minimal cytotoxicity.

Figure 3.1. Synthetic biodegradable elastomer, poly (glycerol-dodecanedioate).

PGD polymers also possess several beneficial characteristics for soft
tissue engineering applications. Stiffer synthetic materials such as poly (hydroxyl
butyrate) and poly (L-lactide) have Young’s moduli of 250 MPa and 660 MPa,
respectively, while the biodegradable polymer PGD displays an elastic property
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similar to rubber, with a Young’s modulus of 1.08 MPa at temperatures above 37
˚C, and as such is a close match to the in-situ Young’s moduli of the peripheral
nerve (0.45 MPa), spinal cord tissue (0.2 MPa-0.8 MPa) and skin (4.2-8.5 MPa)
[18, 159-162]. Moreover, the mechanical and physical properties of PGD can be
tuned for different tissue engineering applications by adjusting its chemical
composition ratio and fabrication processes.

However, like other synthetic

polymers, PGD does not carry proper chemical signals to promote cell adhesion
and proliferation. To address this shortcoming, adding gelatin, a denatured form
of collagen, into a PGD construct is considered.
Gelatin, which is derived from partial hydrolysis of native collagens in
animal skin, tendon, cartilage and bone, has been widely used for
pharmaceuticals, wound dressings and tissue engineering due to its wealth of
merits including biological origin, biodegradability, biocompatibility, formability
and low cost [163-165]. However, the strong hydrogen bond interactions in
gelatin molecules often leads to a three dimensional macromolecular network. As
a result, the mobility of gelatin chains decreases greatly and makes it difficult to
be electrospun alone or requires toxic solvent to dissolve [62]. Since PGD can be
dissolved in most organic solvents and even in a mixture of ethanol and water, it
is interesting to investigate whether PGD and gelatin can be blended and
electrospun into fibers to get hybrid scaffolding materials.
Electrospinning is one of the simplest and most versatile techniques to
produce micro-to-nanometer size fiber scaffolds from polymers or other
materials. The basic principle of electrospinning involves a Taylor cone of
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Figure 3.2. Electrospinning setup including a syringe pump, a high voltage power supply and a
new designed collector.

3.2

Experimental

3.2.1 Determination of PGD molecular weight by Gel Permeation
Chromatography (GPC)/Size Exclusion Chromatography (SEC)
A High Performance Liquid Chromatography (HPLC) system (Perkin
Elmer, Flexar) equipped with a 25 cm long GPC column (Jordi Gel DVB Column5 μ, 250 x 4.6 mm, Mixed Bed, Jordi Labs) was used to determine the PGD
molecular weight (MW). The analog outputs from both the UV detector and the
Evaporative Light Scattering Detector (ELSD) were fed to a data acquisition unit
(BIOPAC, model MP100) to be converted into digital signals. Then the acquired
signals were processed, displayed and stored in a computer for later analysis.
A polystyrene molecular weight standard kit with the MW ranging from 497
Da to 1.03×106 Da (TSK standard POLYSTYRENE, TOSOH, Japan) was used to
establish the calibration curve of MW vs. retention time. For sample preparation,
3 mg of PGD from different time points (24 hours, 72 hours and 96 hours) were
dissolved in 3 mL of Tetrahydrofuran (THF) in a glass vial. The vial was shaken
until the polymer has completely dissolved. Then 100 µl sample was loaded into
the HPLC system with a syringe. Both analog signals of UV and ELSD were
digitalized at a rate of 200 samples per sec. This procedure was repeated three
times for each sample. For data analysis, the data acquired from the BIOPAC
software were imported into a Microsoft Excel spreadsheet. At each sampled
time point, the voltage output of the ELSD was used to calculate the
corresponding MW from the established calibration curve by assuming the
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voltage output is proportional to the numbers of polymer (created by 12
polystyrene standards of differing molecular weights) to calculate the log of the
molecular weight for that sample point. Taking the anti-log of this gave a
molecular weight measurement that was then multiplied by the voltage reading at
that sample point. The product of the molecular weight and voltage measurement
at each of the bounded sampled points, as well as the voltage measurements,
were then summed. Finally, the summed product of molecular weight and voltage
was divided by the summed voltages to calculate the number-average molecular
weight (Mn) using Equation 3.1:
Mn=

∑
∑

=

∑

(3.1)

∑

where Mi is the ith sampled point’s corresponding molecular weight and Vi is the
ith sampled point’s voltage measurement.
By taking the same approach, the following equation was used to
calculate the weight-average molecular weight (Mw):

∑

Mw= ∑

=

∑
∑

(3.2)

3.2.2 Preparation of PGD/gelatin polymer solution and fabrication of
electrospinning fibers
To prepare the polymeric solution for electrospinning, glycerol and
Dodecanedioic acid (DDA) from Sigma-Aldrich (St Louis, MO) were mixed in a
molar ratio of 1:1 and reacted at 120 °C for 100 hours to procure PGD polymers.
Meanwhile, a mixture of poly(ethylene oxide) (PEO), gelatin, and solvent (65%
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ethanol and 35% water) with a combination of 1.5 : 3 : 95.5 (w/w), which was
denominated as the basal solution (BS), was heated in a low temperature oven
and stirred every 10 minutes until it became a homogeneous solution. PEO with
a high average molecular weight (600,000 Da), when combined with PGD,
allowed for synthesis of longer fibers. The testing solutions for making
electrospun fibers were composed of 50% PGD and 50% BS, 40% PGD and 60%
BS, 30% PGD and 70% BS, and 20% PGD and 80% BS, respectively. In addition,
0.1% riboflavin was incorporated into the polymer solution as a photoinitiator for
later crosslinking process. Then the polymeric solution underwent the
electrospinning process described in section 2.3. Additionally, in order to
evaluate the impact of gelatin on fiber forming and cell attachment, polymeric
solutions without gelatin but containing 20-50% PGD concentration were
prepared by dissolving in solvent (65% ethanol and 35% water) and adding 2.6%
(w/w) PEO.
In the typical experimental procedure, the polymeric solution was fed into
a 5 ml standard syringe and delivered through an 18G blunted stainless steel
needle by a syringe pump (Fish scientific, USA) at a flow rate of 0.6 ml/h.
Electrospun fibers were fabricated in an operating voltage of 14.6 kV (SL30,
Spellman High Voltage Electronics Corporation, USA), and the distance between
the needle tip and the ground collector was 25 cm. An aluminum foil strip was
attached perpendicular to a flat metal plate as the electrospinning collector, and
fibers formed across the gap between this strip and the plate. In order to get a
more uniform fiber mat, the syringe pump was placed at an angle of about 15
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degrees with the horizontal to prevent aggregation of fibers at the front of the
strip. After electrospinning, the fibers were exposed to UV light for around 80
minutes to enhance the crosslinking process.
3.2.3 Characterization of PGD/gelatin fiber scaffolds
3.2.3.1 Scanning electron microscopy (SEM) of Electrospun fibers
The electrospun fibers of PGD with and without gelatin were analyzed
using scanning electron microscopy (SEM, JEOL JSM6330F, Tokyo, Japan) at
various magnifications. Before imaging, the fiber samples were placed in a gold
sputter coater for 2 minutes to deposit a thin conductive film. The average
diameters of the fibers were determined by means of Image J 1.47v software at
100 different locations of the SEM images.
3.2.3.2 Raman spectroscopy
Raman spectra were taken with Raman Micro 400 Series Raman
Spectroscopy (Perkin Elmer) using a 50X objective lens and with a 2-second
exposure time. These spectrum data were used to evaluate the polymerization
process and the chemical structures of PGD, gelatin and their mixture pre- and
post-electrospinning. The samples were taped to the shiny side of an aluminum
foil covering the microscope slides [167].
3.2.3.3 Dissolvability test
Fiber samples, which had already been exposed to UV light for 80 minutes,
were cut into small round pieces of the same size and placed into 60-mm culture
dishes. Two milliliters of the Phosphate Buffered Saline (PBS) were added to
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each plate and the plates were kept at 37 °C for one month to test the
dissolvability of the cross-linked scaffolds.
3.2.4 In vitro studies of PGD/gelatin fibers with human foreskin fibroblasts
3.2.4.1 Cell seeding
Human Foreskin Fibroblasts (HFF) cells acquired from Globstem
(Rockville, Maryland) were used to test cell viability on the PGD fiber scaffolds
with and without gelatin. These cells were cultured in a medium that consisted of
90% DMEM/F12 basal medium (Thermo Scientific), 1x antibiotics/antimycotics
and 10% fetal bovine serum (FBS) (Sigma-Aldrich, St Louis, MO). Fiber samples
made from different compositions were cut into small round pieces of the same
size and placed into a 6-well plate with low cell binding surface (Nunc, Fisher
Scientific). For pre-seeding treatment, specimens were soaked in PBS for 3
hours and subsequently immersed in fresh medium and kept at 37 °C overnight.
Before seeding, cells were counted using a hemocytometer and then seeded to
the scaffolds at a 5.0×104 cells/well density. Following the addition of the cell
suspension droplet, the fiber mats were kept in an incubator at 37 °C and 5%
CO2 to allow cell attachment.
3.2.4.2 Visualization of cells on the fibers
In order to visualize cells on the fiber scaffolds, Calcein AM, a cellpermeant dye purchased from Invitrogen (Grand Island, NY) was used to stain
the live HFF cells. After culturing the cells at 5.0 ×104 cells/well density for 1 day,
1 µl of the Calcein AM reagent was added into 2 ml of cell culture medium and
incubated for one hour. Thereafter, the fluorescence signal from the cells was
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visualized under the confocal microscope (D-Eclipse C1, Nikon) by using an
excitation wavelength of 488 nm.
3.2.4.3 Evaluation of cellular viability
Resazurin fluorescence dye (Sigma-Aldrich, St Louis, MO), which had
been shown to be identical to the commercial assay Alamar Blue [141], was used
as an index of cellular viability [168]. After 24 hours cell culturing on the scaffold,
the culture medium was drained and 100 µl of the reagent were added to each
well, mixed with 2 ml of fresh medium. Background controls of 2 ml of medium
plus 100 µl of the resazurin reagent were also performed. The plate was placed
in an incubator at 37 °C and 5% CO2 for 4 hours to allow the cells to metabolize
the resazurin. Then 100 µl medium samples of the different composition of fiber
mats as well as the control group (sample numbers in each group, n=4;
experiment was repeated 3 times), were collected into a 96-well plate in triplicate.
Thereafter, the 96-well plate reader was set to measure the fluorescence
intensity of a 590 nm emission with an excitation wavelength of 530 nm. The
same procedure was repeated at different time points (1 day, 3 days, 5 days and
8 days). Subsequently, the data of fluorescent intensity were converted to cell
numbers according to the established standard curve (known cells number v.s.
fluorescent intensity), and used to compare the number of metabolically active
cells in different samples.
3.2.5 Statistics
Analysis of variance (ANOVA) and Turkey’s HSD tests were used to
evaluate the significance between the PGD with gelatin fibers, PGD without
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gelatin fibers and control group (n = 4) for cell viability testing. Kruskal-Wallis
Test and Mann–Whitney U-test were performed to determine the statistical
difference between groups in fiber diameter distribution. In both cases, the
statistical significance was set at p < 0.05.
3.3

Results

3.3.1 Characterization of PGD polymer
3.3.1.1 Determination of PGD molecular weight
An HPLC system combined with a GPC/SEC column is the most
convenient method to measure the MW of polymers and their MW distributions.
In this study, two detectors (UV and ELSD) were used to monitor the elution of
polymers. It was found that PGD polymers were almost invisible in the UV
detector. Therefore, detection of the elution time for PGD polymers was
performed by ELSD. The determined number/weight average molecular weights
of PGD at 24 hours, 72 hours and 96 hours are shown in figure 2.3, which were
in the order correlated to its overall reaction time. Table 3.1. shows the different
Mw and Mn of PGD and the polydispersity index, Mw /Mn. The larger the index, the
wider the polymer molecular weight distribution is [169].
Table 3.1. Number- and Weight- average molecular weight and the polydispersity
index of PGD on different time points.
Number-Average
Weight-Average

PGD 24 hours

Molecular Weight

Molecular Weight

Polydispersity

(Mn)

(Mw)

index

1354

2184

1.61249

70

PGD 72 ho
ours

6535

19152

2.93067

PGD 96 ho
ours

20463

111270

5.43738
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Figure 3.4. Raman spectra of DDA, glycerol and PGD, respectively

3.3.2 Characterization of PGD/gelatin electrospun fibers
3.3.2.1 The newly designed collector and the effects of PGD concentration on
fiber size
By adopting our newly developed electrospinning collector, PGD was
dissolved in 65% ethanol/ 35% water and electrospun from the solution
containing 20%-50 %( w/w) PGD, and the fibers were deposited between the
aluminum foil strip and the aluminum plate (Figure 3.5). From figure 3.5A, it is
clear that the fibers were spanning between the strip and the plate, thus the fiber
mats could be easily harvested without the risk of damaging to the fibers. In
contrast, when using a traditional collector, i.e. a flat metal plate, the fibers
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attached strongly to the collector surface, and it was unable to easily harvest an
intact fiber mat. In addition, the aluminum foil strip could be adjusted to fabricate
different sizes of fiber mats. For example, the fiber mat could be easily obtained
in the size of 9 cm by 15 cm as shown in figure 3.5B and 3.5C.
Incorporating 2-3% (w/w) gelatin into the polymeric solution with 20-50%
(w/w) PGD was also investigated and found that PGD blended with gelatin can
be also electrospun into fibers. Another important observation was that a small
amount (1-2%) of the high molecular weight PEO would result in better long fiber
obtainment, therefore PEO was used in all studies. Furthermore, fibrous
scaffolds were examined by using SEM to determine the diameters and
morphologies of the fibers. One hundred randomly selected areas were chosen
from the SEM images shown in figure 3.6 to calculate the average diameters of
the fibers in each group. As shown in figure 3.6, the fibers produced from 30%
(w/w) PGD solution had the smallest diameters, with a mean diameter of
0.95±0.91 μm. It is observed that when using higher PGD concentration,
increased fiber diameters are acquired with mean diameters of 3.33±1.71 and
4.93±7.28 μm. The results also showed that the polymeric solution with 20%
PGD polymer was not able to produce electrospun fibers. This result indicated
that PGD concentration has a significant effect on the electrospun fiber diameter.
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Figure 3.7. Raman spectra of PGD/BS fibers prior to and after electrospinning.

3.3.2.3 Fiber dissolvability
Dissolvability testing of the PGD with gelatin scaffolds was performed to
study the stability of the fibers in PBS at 37 °C for four weeks. The fibers without
crosslinking dissolved in PBS quickly (data not shown). In order to increase its
stability, riboflavin, which is a photo initiator, was incorporated into the polymeric
solution before electrospinning. Since ultraviolet (UV) light was used to sterilize
the fibers, it is worth of investigating whether UV light could be, simultaneously,
used for sterilization and crosslinking. After being exposed to UV light for 80
minutes, the fiber scaffolds maintained its structural integrity in PBS for a one
month. Figure 3.8 shows the change in morphology and structure of the PGD
with gelatin fibers during the degradation process. Compared to figure 3.6, the
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morphology of some of the fibers changed after 4 days (Figure 3.8A) and this
change became more obvious after two weeks, which is reflected by the fact that
fibers were swelling and fused together (Figure 3.8B). On day 28, under higher
magnification, even though some fibers were broken down into short pieces, the
fiber structure was mostly preserved (Figure 3.8C).

Figure 3.8. Surface morphology of the degraded PGD with gelatin fibers after different time points.
PGD with gelatin fibers after (A) 4 days; (B) 14 days and (C) 28 days.

3.3.3 In vitro studies of PGD/gelatin fiber scaffolds
3.3.3.1 Visualization of cells on fiber scaffolds
Calcein AM, a cell-permeant dye, was used to visualize the live cells in
PGD fibrous scaffolds. In live cells, the nonfluorescent calcein AM is converted to
a green-fluorescent calcein after acetoxymethyl ester hydrolysis by intracellular
esterases. After 1 day of cultivation of HFFs on fiber scaffolds in a 6-well low
adherent plate as well as cultivation of the control group cells on the 35 mm
tissue culture dish without fibers, Calcein AM dye was added and confocal
microscopy was used to acquire the fluorescent images. The cell morphology on
the two surfaces was considerably different. On the fiber scaffold, most cells
attached to the fibers exhibited round shapes with less spreading, although a
small fraction of cells developed multi-cell clusters (Figure 3.9A). In contrast, on
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th
he 35 mm tissue
t
cultu
ure dish witthout fiberss, the fibrob
blasts were
e well-sprea
ading
across the entire
e
surface when observed un
nder the co
onfocal micrroscope (Fiigure
3.9B).

Figure 3.9. Cell adhesion on
n the PGD with gelatin fibe
ers after 1 dayy culture. HFF
F cells stainin
ng
with
w Calcein AM reagents (b
bright green, arrows) on th
he scaffold (A
A) and tissue cculture dish (B
B).
Scale bar: 50 µm.
µ

3.3.3.2 Cell viability
The proliferation
n of the ce
ells on the
e PGD fibe
ers as well as the tissue
culture dishe
es was com
mpared by using Ressazurin asssay. This assay meassured
th
he metabolic activity of
o the culturred cells an
nd the fluorrescence in
ntensity rea
ading
of the cell cu
ulture medium reflecte
ed the degrree of viabillity. HFFs w
were seede
ed on
PGD
P
scaffolds with and
d without gelatin as well as tissue
e culture diishes at the
e cell
density of 5..0×104 for up
u to 8 days
s. Figure 3..10 shows tthat the cellls grown on
n the
PGD
P
with gelatin
g
fiberrs had equ
uivalent or better celll viability th
han the co
ontrol
group during
g the first 3 days. This could be due to the
e scaffolds providing m
more
surface area for cell growth, wh
hen compa
ared to the
e two dimensional tissue
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culture dishe
es. Cells on the PGD without ge
elatin fiberss exhibited relatively lower
er two group
ps. Overall, cells seed
ded on the PGD
proliferation compared to the othe
g
were
e comparable to cellss grown in tissue cultture dishess, but
fibers with gelatin
cells on the
e PGD fibers without gelatin con
ntinued to grow at a slow rate. This
in
ndicates tha
at gelatin is
s an essential part of ccell adhesio
on and survvival on the fiber
scaffolds.

Figure 3.10. Resazurin
R
ass
say showing the cell viab
bility on PGD
D with Gelatin fibers and PGD
without
w
gelatin
n fibers after 1,
1 3, 5, and 8 days. Cells directly culturred on the tisssue culture d
dishes
us
sed as contro
ol. Sample nu
umber in eacch group, n=44. Average vvalues and sttandard errorrs are
frrom three rep
plicate experiments.*p<0.0
05.

3.4 Discussiion
Comp
pared to co
onventional autograftss and allogrrafts, tissue
e engineering is
an alternativ
ve strategy
y enabling tissues or organs in the body tto be made de
novo. It gen
nerally involves the us
se of cells cultured on
n scaffolds in combination
meet
with
w
biologic
cal factors
s. Scaffolds
s in tissue
e engineering are req
quired to m

79

certain minimum requirements for biochemical and physical properties, namely,
mechanical stability, biocompatibility, and topography.
PGD is a biodegradable elastomeric polymer synthesized from glycerol
and DDA. It is biocompatible, exhibits elastic behavior and unique shape memory
[19]. The Mn and Mw of PGD after 4 days are approximately 20 and 111 kDa,
respectively. The fibrous scaffolds made from PGD provide a good solution for
soft tissue engineering because their elastic properties better match the
mechanical properties of soft tissues when compared to other stiffer synthetic
polymers. The properties of the electrospun fiber are greatly influenced by
several processes and solution parameters. The composition of the polymeric
solution is extremely important for achieving ideal fiber scaffolds. PGD
concentration ranging from 30% to 50% (w/w) with and without gelatin can
generally produce the desired fiber mats. Increasing PGD concentration raises
the viscosity of the polymer solution resulting in fibers with larger diameter size
as well as a smaller porous structure. Although decreasing the PGD
concentration will lessen the diameter of the fiber, there is a greater chance of
having drops on the fiber mat.
With other synthetic polymers like PLGA and PCL for electrospinning
PLGA/Gelatin/Elastin [172] and PCL/Gelatin fibers, more expensive and toxic
solvents such as hexafluoro-2-proponol and trifluoroethanol are required to
dissolve gelatin, elastin and polymers. In contrast, PGD can be easily dissolved
in solvents like a mixture of ethanol and water, thus incorporation of watersoluble biomolecules such as gelatin into PGD in our study became a
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straightforward job. The advantages of using a less toxic solvent like ethanol
include fabrication flexibility and minimizing the safety concern.
Furthermore, it is also interesting to monitor the chemical structure
changes during the PGD polymerization and electrospinning fabrication. DDA is
a molecule with carboxylic groups at both ends, and glycerol has three free
hydroxyl groups. During the polymerization process, these two functional groups
react to form a new ester bond after removing one water molecule. Glycerol with
three hydroxyl groups allows the polymer to form branch structures and results in
a three dimensional network after curing. The C=O stretch, which appears at
1730-1740 cm-1 on raman spectra, was an indication of ester bonds and was
present in the PGD polymer, PGD/Gelatin blend and the final electrospun fibers.
The similarities in the Raman spectra of pre- and post-electrospun polymers
demonstrated that the electrospinning process did not change the chemical
structure of the polymer.
Crosslinking of electrospun fibers is carried out in an attempt to preserve
the scaffold fibrous architecture. The fiber scaffolds before crosslinking dissolved
quickly in PBS at 37 °C (Data not shown). Therefore, it is essential to stabilize
the scaffold by using a crosslinking agent, which would preferably be nontoxic to
the cells. Riboflavin, before known as vitamin B2 or additive E101, is an easily
absorbed micronutrient with a key role in maintaining health in humans and
animals [173]. According to the previous study, it also acts as a photo initiator to
crosslink collagen with the help of short UV exposure for eye treatment [174,
175]. In this study, 0.1% riboflavin was incorporated into the polymer solution
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before electrospinning, and after the fiber mat was collected, it was exposed to
UV light for around 80 minutes. Compared to the scaffold, which was not
crosslinked, the crosslinked fiber mat could grossly maintain its structural
integrity in PBS at 37 °C for up to 28 days.
The continuous increase in cell numbers on the PGD with gelatin fiber
scaffolds over a period of 8 days indicated that cell proliferation took place on
these fiber mats, similar to the traditional 2 dimensional culture dish. In contrast,
cells on the PGD without gelatin fibers exhibited relatively slower proliferation.
This suggests that the natural polymer gelatin plays a key role in cell adhesion
and proliferation. Both PGD and PEO are synthetic polymers; hence there are no
binding sites for cells to attach to. Gelatin derived from collagen provides sites
(ligands) for cell adhesion thus improving cell proliferation. Therefore, PGD
blended with gelatin also exhibits similar properties for promoting cell adhesion
and proliferation, which in turn enhances the fiber mat biocompatibility.
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CHAPTER 4 Modification of Electrospun Fiber Scaffolds Composed of PGDF for
Neural Tissue Engineering.
4.1 Introduction
Biomaterials play a vital role in tissue engineering because it is the key
ingredient of the scaffolds created to facilitate cell attachment, proliferation,
differentiation, and, ultimately, new tissue formation.

Many techniques have

been developed for 3D scaffolds fabrication over the past 20 years. Recently,
micro/nanofiber-based scaffolds produced via the electrospinning technique are
gaining increasing interests since it offers the opportunity for control over the
composition of the fibers along with porosity of the fiber meshes using a relatively
simple experimental setup. Structurewise, electrospun fiber scaffolds bear a
strong resemblance to the hierarchical structure of the extracellular matrix (ECM),
an environment critical for cell survival, differentiation, signal transduction and
nutrient/waste transport [13]. Furthermore, electrospun fibers can be modified
using different physical or chemical methods to encapsulate or attach bioactive
molecules such as native ECM proteins or RGD peptides to support and guide
both the survival and differentiation of cells seeded on the scaffold. All these
attributes make electrospun fibers a new class of promising scaffolds for neural
tissue engineering.
4.1.1 Embedding Biomolecules into fiber Scaffolds for Neural Tissue
Regeneration
While scaffold-based approaches have been utilized in the past to support
the repair of neural tissue, a fundamental limitation of these strategies is the lack
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of appropriate biomolecules embedded in the scaffold. Without the presence of
these biomolecules, continuous delivery requires a stream of complex surgical
procedures to inject them into the site of injury [176]. Unfortunately, this does not
ensure that the concentrations of these biomolecules remains constant over the
duration of release.
Ever since the development of polymer-based implantable therapies,
scientists have worked hard to learn how to further functionalize these surfaces
in order to create specialized cell surface interactions.

Two fundamental

methods exist for coating polymers – using proteins and using peptides [177].
Adhesive proteins such as fibronectin, collagen and laminin were initially
considered and tested, but they are often purified from other organisms and
hence may create an immune response. In addition, due to their large size, it is
not certain if their orientation at any particular moment will be suitable for cell
adhesion. Finally, they are potential targets of proteolytic degradation; therefore,
their concentration will not be constant over time. On the other hand, peptides
have emerged as a superior option due to their enhanced stability and higher
potential packing density.

While protein-based options originating as ECM

components have the potential to activate a variety of cell recognition motifs due
to their size, peptides are far more selective and can activate single motifs.
Therefore the RGD-sequence and laminin were chosen as the biomolecular
peptides of this study.
4.1.2 Functions of poly (glycerol- dodecanedioate co-fumarate)
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PGDF is a novel polymer derived from previously researched polymer
PGD [143]. PGD was chosen as a base for the polymer since its mechanical
properties are suitable for soft tissue engineering. PGD is advantageous since its
synthesis is simple, non-toxic and has good biocompatibility. In addition, the
diameter of derived fibers can be adjusted easily by changing the concentration
of PGD.
One disadvantage of the PGD polymer is that it is composed of saturated
polyester chains that only have hydroxyl or carboxylic groups available for
chemical modification. If another double-bond containing monomer is introduced,
the resulting polymers with unsaturated polyester chains may provide new
modification possibilities. These properties, in turn, can be used to modify PGD
fibers and facilitate cell attachments. For this reason, Fumaric acid, a non-toxic,
naturally occurring monomer, was incorporated into the PGD polymer synthesis
process

and

produced

a

PGD

derivative

referred

as

poly

(glycerol

dodecanedioate co-fumarate) (PGDF). Fumaric acid has also been demonstrated
to be both neuroprotective and cardioprotective through activation of the Nrf2
antioxidant pathway [127, 128]. Sodium Fumarate (NaF) is derived from Fumaric
Acid, which is a metabolite and intermediate product of the citric acid cycle [129].
Time-dependent and concentration-dependent studies have been carried out that
demonstrate NaF to be immunomodulatory and able to reduce oxidative stress
without altering fundamental network activity.

In vitro, its addition has been

shown to improve neuronal survival [178]. In vivo, fumarate works to better
preserve the integrity of myelin, axons and neurons. The choice to add it to the
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experimental protocol was due to a fundamental belief that its preservative ability
would impact cell survival and induction efficiency.
4.1.3 Peptides modification on the synthetic polymers
The use of synthetic polymers modified with peptides containing RGD (the
cell recognition motif) not only triggers cell adhesion but can be used to
selectively modify the activity of certain cell lines [177].

The RGD peptide

sequence is useful for stimulating adhesion through the activation of integrinfamily cell adhesion receptors. Integrins are not only used for physical anchoring
but also promote signal transduction through the membrane of the cell.
Laminin was chosen as a biomolecule to integrate into the scaffold since it
is a naturally occurring ECM protein that promotes the formation of neurites [179].
It provides a local environment that mimics neural tissue and can be added using
covalent binding or physical adsorption.

Laminin is continuously synthesized

after nerve injury and plays essential roles in cell migration, differentiation and
the growth and elongation of axons. Myelinating phenotypes of Schwann cells
cannot occur without the presence of laminin. Laminin has been used previously
in electrospinning, for example, incorporated into electrospun poly(L-lactic acid)co-poly(e-caprolactone) (PLCL) [180]. This research is the first documented use
of laminin on the electrospun PGDF scaffold and based on the properties of
laminin there is a reason to believe this choice is essential to ensure neural
growth and survival.
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4.2

Experimental

4.2.1 PGDF fiber design and fabrication
PGDF polymer was made from glycerol, DDA and Fumaric acid (FA) (St
Louis, MO) (Figure 4.1A). To begin with, glycerol and DDA were mixed in beaker
1 in a molar ratio of 0.6:0:2 and glycerol plus FA in beaker 2 in a molar ratio of
0.4:0.8. These two beakers were kept at 120 °C for 72 hours until both the acids
have been completely reacted with glycerol. Then the pre-polymers in both
beakers were mixed together and kept at the same temperature for another 24
hours to procure PGDF polymer. For basal solution (BS) preparation, a mixture
of poly (ethylene oxide) (PEO), gelatin, and solvent (65% ethanol and 35% water)
with a combination of 1.5 : 3 : 95.5 (w/w), was heated in a low temperature oven
(around 65°C) with stirring every 10 minutes until it became a homogeneous
solution. The testing solutions for fabricating electrospun fibers were composed
of 60% polymer (PGDF:PGD=5:5) and 40% BS, 50% polymer and 50% BS, 40%
polymer and 60% BS, and 30% polymer and 70% BS, respectively. In addition,
0.1% riboflavin was incorporated into the polymer solution as a photoinitiator for
later crosslinking and peptides immobilization process. These polymeric solution
were then underwent the electrospinning process.
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Figure 4.1. (A) Synthetic bio
odegradable elastomer,
e
po
oly (glycerol-d
dodecanedioa
ate co-fumara
ate).
(B
B) RGDC imm
mobilization.

PGDF
F fiber scaffolds we
ere fabricatted as pre
eviously de
escribed [143].
Briefly,
B
poly
ymer solutio
on was fed
d into an 8 ml standa
ard syringe
e and delivvered
th
hrough an 18G
1
blunted
d stainless steel need
dle by a syrringe pump (Fish scien
ntific,
USA)
U
at a flow rate of
o 0.5 ml/h
h. The ope
erating volttage was 1
14.6 kV (S
SL30,
Spellman
S
High Voltage
e Electroniics Corpora
ation, USA
A) and the distance ra
ange
between the
e needle tip
p and the grround colle
ector was 18
8-25 cm de
epending on
n the
different concentration
n of the po
olymer sol ution.

An
n aluminum
m foil strip was

m
plate as the elecctrospinning collector,, and
attached perpendicularr to a flat metal
he gap betw
ween this sstrip and the
e plate. The syringe p
pump
fibers formed across th
was
w placed at an angle
e of 15 deg
grees with tthe horizon
ntal to preve
ent aggregation
of the fibers
s at the fron
nt of the sttrip. Fiber m
mats were exposed to
o UV light for 2
hours to enh
hance the crosslinking
c
process.
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4.2.2 Characterization of PGDF fiber scaffolds
4.2.2.1 SEM
The electrospun fibers of PGDF in different concentration were analyzed
using Scanning Electron Microscopy (SEM, JEOL JSM6330F, Tokyo, Japan) at
various magnifications. Before imaging, the fiber samples were placed in an Auto
sputter coater (PELCO SC-7) for 50 sec to deposit a thin Au conductive film. The
average diameters of the fibers were determined by means of Image J 1.47v
software at 100 different locations of the 500X SEM images.
4.2.2.2 Dissolvability test
After 2 hours UV exposures, electrospun fiber mats were cut into round
pieces of the same size and placed into 24-well plate for dissolvability test. One
milliliters of the Phosphate Buffered Saline (PBS) were added to each well and
the plate was kept at 37 °C for up to 2 month to test the dissolvability of the
scaffolds.
4.2.2.3 FA Release Behaviors of Electrospun fiber
The electrospun fiber mats were sectioned into round pieces and each
sample was incubated into 10 mL of PBS at 37 °C. Samples of 1 mL released
solution were taken from the incubation solution at 3 h, 24 h, 72 h, 96 h, 150 h,
168 h, 192 h, 216 h, 240 h, 264 h, 336 h and 360 h after incubation, while an
equal amount of fresh PBS was added back to the dissolution medium. The
amount of FA was detected with a UV spectrophotometer (Synergy HT, BioTek)
at a maximal absorption peak of 230 nm. For standard samples with a
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concentration from 15 μM to 1000 μM was determined between the absorption
strength and FA concentration.
4.2.2.4 Raman spectroscopy
Raman spectra were taken with Raman Micro 400 Series Raman
Spectroscopy (Perkin Elmer) using a 50X objective lens and with a 2-second
exposure time. These spectrum data were used to evaluate the polymerization
process and the chemical structures of PGD and PGDF. The samples were
taped to the shiny side of an aluminum foil covering the microscope slides[167].
4.2.2.5 Peptides Immobilization
The fiber mats were first cut into round pieces and placed into 24-well
plate. They were then incubated with RGDC peptides or Laminin peptides or
PBS as a control and exposed to blue light for 3 hours. Thereafter, the samples
were kept in incubator at 37 °C for another hour and then washed with PBS twice
to get rid of the unbonded peptides. Fiber samples treated in different groups
were dissolved in 95% ethanol. Then the dissolution medium were transferred to
UV-Cuvette (BRAND, Sigma-Aldrich) and read with UV spectrophotometer.
4.2.3 In vitro studies of PGDF fibers with mouse embryonic stem cells
4.2.3.1 Cell seeding and distribution
Fiber samples made from different PGDF concentration were cut into
small round pieces of the same size and placed into a 24-well. For pre-seeding
treatment, specimens were soaked in peptides or PBS (as control) for 3 h under
blue light and subsequently immersed in fresh medium and kept at 37 °C
overnight. Before seeding, cells were counted using a hemocytometer and then
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seeded to the scaffolds at a 5.0×104 cells/well density. Following the addition of
the cell suspension droplet, the fiber mats were kept in an incubator at 37 °C and
5% CO2 to allow cell attachment.
4.2.3.2 Cell attachment and survival
Resazurin fluorescence dye (Sigma-Aldrich, St Louis, MO), which had
been shown to be identical to the commercial assay Alamar Blue [141], were
applied as an index of cellular viability [168]. The resazurin reagent was mixed
with fresh medium in 1:10 (v/v) and added to each well. Cell culture plate was
kept in an incubator at 37 °C and 5% CO2 for 4 h to allow the cells to metabolize
the resazurin. Then 100 µl resazurin/medium mixture of different well were
collected into a 96-well plate in triplicate. Then the 96-well plate reader was set to
measure the fluorescence intensity of a 590 nm emission with an excitation
wavelength of 530 nm. The same procedure was repeated at different time points
(day4, day6, day8 and day11).
4.2.3.3 Phenotype expression
Phenotype expression of the cells on PGDF fiber was examined through
real-time PCR. Total RNA was prepared from fiber cell culture sample on Day 11
using SV Total RNA Isolation System (Promega). Each mRNA preparations was
reverse transcribed into cDNA using olig(dT)15, as described by the manufacturer
(GoScript Reverse Transcription System, Promega). Real-time PCR was
performed on a Real Time PCR System (Applied Biosystems). For amplification,
the cycling parameters consist of 1 cycle at 95 ˚C for 2 min and 20 s, followed by
40 cycles of 95 ˚C for 3 s and 60 ˚C for 1 min. The comparative CT method was
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utilized to calculate the relative expression of each target gene, and each is
normalized relative to the house keeping gene expression of glyceraldehydes-3phosphate dehydrogenase (GAPDH) mRNA.
4.2.3.4. Statistics
Kruskal-Wallis Test and Mann–Whitney U-test were performed to
determine the statistical difference between groups in fiber diameter distribution.
In both cases, the statistical significance was set at p < 0.01. Analysis of variance
(ANOVA) and Turkey’s HSD tests were used to evaluate the significance
between the PGDF-RGDC, PGDF-Laminin and PGDF group (Sample number in
each group: n = 3, experiment was repeated 3 times) for peptides binding and
cell viability testing.
4.3 Results
4.3.1 Characterization of PGDF electrospun fibers
4.3.1.1 Fabrication of scaffolds with different fiber diameter
Electrospun fiber scaffolds were examined by using SEM to determine the
morphology and diameter of the fibers. By varying the concentration of PGDF
(30%, 40%, 50%, 60%), electrospun fibers of various diameters could be
generated (Figure 4.2 A-D). A histogram of the fiber diameters for each polymer
concentration was conducted to examine the fiber diameter distribution (Figure
4.2 E-H).

Diameters were measured using SEM pictures and 100 randomly

selected areas were averaged. A significant difference was seen in the mean
fiber diameter of 30% (1.756 ± 0.813 µm), 40% (2.597 ± 0.765 µm), 50% (3.697
± 0.807 µm) and 60% (4.925 ± 2.148 µm). It is evident that the spread of fiber
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diameters re
emains sma
all until the PGDF con
ncentration reaches 60
0% and tha
at the
on of the PG
GDF contro
ols the diam
meter of the
e generated
d fiber matrrices.
concentratio
The
T
results of the Krruskal–Wallis test an
nd Mann–W
Whitney U--test showe
ed a
significant difference be
etween eac
ch possible pair of gro
oups within the four op
ptions
(p
p<0.001).
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Figure 4.2. SE
EM images (A
A-D) and diam
meter distribu
ution (E-H) off electrospun PGDF fiberss from
(A
A,E) 30%, (B,F) 40%, and (C,G) 50% an
nd (D,H) 60%
% (w/w) polym
meric solution.. Scale bar: 10 μm.
The results of the Kruskal–W
Wallis test an
nd Mann–Whi tney U-test showed that th
here is a significant
difference betw
ween each po
ossible pair of
o two groups (p<0.001). D
Diameters werre measured using
SEM pictures and
a 100 randomly selected
d areas were averaged.

4.3.1.2 Electrospun fibe
er dissolvab
bility
Disso
olvability tes
st of the PG
GDF fiber sscaffolds w
was perform
med to studyy the
sttability of th
he fibers in PBS at 37 °C for up tto 2 monthss (Figure 4.3). This te
est is
im
mportant since an ultim
mate goal of this fibe r scaffold iss implantattion in the body
fo
or injury re
epair.

By validating the stabiliity of these
e fibers, itt could help to

understand the viability
y of these scaffolds
s
forr long-term therapy. A
As mentioned in
th
he previous
s paper [14
43], a photo
o initiator ca
alled ribofla
avin was in
ncorporated
d into
th
he polymerr solution before
b
elec
ctrospinning
g. Figure 4
4.3 shows the chang
ge in
sttructure of the PGDF
F fibers du
uring the d
degradation
n. There w
was no obvvious
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morphology
m
change during the first
f
month .

Even th
hough fiberrs were broken

down into sh
hort pieces after 2 mon
nths, the fib
ber structurre was mosstly preserve
ed.

Figure 4.3. Surrface morpho
ology of PGDF
F fibers on (A
A) Day 1, (B) D
Day 14, (C) D
Day 32 and (D
D) Day
64
4. UV crossliinking was us
sed to preserv
ve the overall architecture in order to prrevent rapid
de
egradation.

4.3.1.3 Fumaric acid re
elease profile from elecctrospun fib
bers
F is a bio
odegradablle polymerr and thuss it is alsso valuable to
PGDF
understand how quickly FA is rele
eased into the surrou
unding tissu
ue. Using a UV
ometer, FA
A can be detected
d
at a wavelen
ngth of 230
0 nm. The
e FA
spectrophoto
r
profile of PG
GDF fibers with differe
ent concenttration is sh
hown
cumulative releasing
in
n Figure 4.4. Sustaine
ed release of FA from
m PGDF fibers was o
obtained fo
or 15
days, with litttle change
e in the rate
e by which iit was relea
ased. From Figure 4.3
3, it is
not difficult to
t notice th
hat fiber mo
orphology re
emained re
elatively uncchanged du
uring
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th
he first mon
nth, with the most significant cha
anges occu
urring betw
ween month
h one
and two. Th
he mainten
nance of fib
ber morphollogy over this first mo
onth is likelyy the
primary cau
use of the linearity off the FA re
elease proffile over th
his time pe
eriod.
These
T
results suggest that diffu
usion proce
esses from
m the fiber surface a
are a
sttronger mechanism off FA release
e than bulkk flow throug
gh degrada
ation of the fiber
scaffold.

Figure 4.4. Releasing profile
e of FA from PGDF
P
electro
ospun fibers. Concentration unit: μM.
Sample numbe
er in each gro
oup: n = 3, ex
xperiment wass repeated 3 ttimes

4.3.1.4 Ram
man spectro
oscopy
Rama
an spectros
scopy was used to in
nvestigate the chemiccal structure of
PGDF
P
and PGD polym
mer. Figure
e 4.5 show
ws the specctra of these 2 polym
mers,
re
espectively. During the
e polymer synthesis,
s
tthe carboxyylic group in
n DDA (-CO
OOH,
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1644.60 cm
m-1) reacted with hydro
oxyl groupss in glycero
ol (-OH, 12
251.13 cm--1) to
orm a new
w ester bon
nd (C=O, around 17
735 cm-1) a
after removving one w
water
fo
molecule.
m
This is demo
onstrated in the specctrum of bo
oth polymerrs. Other bands
around 1297
7 cm-1 and 1438 cm-1 are due to
o C-C strettching vibra
ations, and CH2
tw
wist vibratio
ons and deformation
d
ns, respect ively. The only struccture differrence
between PG
GDF and PGD
P
is at band 166
65 cm-1, w
which represents the C=C
ntroduced from FA. Th
his double bond
b
will brreak and re
eact with the
e Thiol group in
in
RGDC
R
or lam
minin peptid
de, which is
s called Micchael addition.

Figure 4.5. Raman spectra of PGDF and
d PGD, respecctively. Double bond from FA was brought
nto the polyme
er for function
nal modificatio
on purpose.
in
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4.3.2 Effect of peptides immobilized fibers on cell viability
4.3.2.1 UV detection of peptides binding
Using UV spectroscopy, it is simple to detect the presence of the double
bond in FA. Since the RGDC and laminin peptides break this double bond when
bound to the polymer, there should be a significant difference in the double bond
concentration with and without the peptides (Figure 4.6). To determine the µM
concentration

of

double

bond

from

the

absorbance

value

of

the

spectrophotometer, a standardized curve was developed using different
concentrations of FA. As a control, the fiber was incubated with PBS alone as
compared to the experimental groups where it was incubated with the RGDC and
Laminin peptides. In the control group, regardless of the polymer concentration,
a higher concentration of the double bond FA was detected and expected since it
would be retained, instead of being broken to bind the peptides as in the two
experimental groups.
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Figure 4.6. Co
oncentration of
o double bon
nded in PGD F fiber with a
and without presence of pe
eptide
grroups. The binding off each pep
ptide group was meassured individ
dually using
g UV
sp
pectrophotom
metry to ensu
ure that it broke the doub
ble bond to bind to the PGDF. Significant
differences are
e indicated in
n the figure with
w an asterissk. Sample n
number in eaach group: n = 3,
exxperiment waas repeated 2 times (p<0.0
01).

4.3.2.2 Cell viability witthin the sca
affold
Cell viability
v
on PGDF and
d PGDF-mo
odified fiberrs was evaluated by u
using
Resazurin
R
assay,
a
whic
ch measures the me
etabolic acttivity of the
e cultured cells
based on th
he fluoresc
cent intensity reading.. Mouse ESCs were seeded on
n the
fiber mats at
a a cell de
ensity of 5.0×104 for 11 days. F
Figure 4.7 shows the
e cell
viability of PGDF
P
and
d peptide-m
modified PG
GDF resultt as well a
as the confocal
microscopy
m
images. While
W
mES
SCs were p
plated on d
day 0, by d
day 4 theyy had
begun differrentiating in
nto neural stem
s
cells. These cells grown on
n the fiber w
were
fa
ar more via
able with th
he peptides
s than witho
out them. Although tthere was n
not a
significant difference
d
between viability
v
us ing RGDC
C versus L
Laminin ass the
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peptide of choice,
c
therre was a very
v
significcant differe
ence between peptide
e and
m
Th
hese resultts are especcially imporrtant on dayy 11,
non-peptide polymer matrices.
when
w
the cells beca
ame maturre motor neurons.

Results from confocal

microscopy
m
clearly sho
ow a strong
g difference
e in cell via
ability betwe
een these tthree
groups (Figu
ure 4.7 B-D
D).

Figure 4.7. (A)) Resazurin assay
a
showing
g the cell viab
bility on PGD
DF and peptides modified P
PGDF
fib
bers on day 4, 6, 8, and 11. *p<0.01. Sample num
mber in each group: n = 3
3, experimen
nt was
re
epeated 3 times (p<0.01). (B-D) Visualiz
zation of cellss on fiber scafffolds contain
ning (B) RGDC
C, (C)
La
aminin and (D)
(
Control after
a
10 days of culture. T
The green do
ots in the co
onfocal microsscope
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Scale bar: 10
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examined based upon the different diameter of the fiber (Figure 4.8A) and the
presence of 2 peptide groups on day 11 (Figure 4.8 B, C). In addition, PGD was
examined using real time PCR as an additional control to assess the effects of
FA on motor neuron differentiation (Figures 4.8B, C). Although many of the
markers did not express differently between the experimental groups, the 40%
PGDF polymer was chosen for further study due to the clear upregulation of HB9
and downregulation of GFAP compared to the alternative concentrations of
PGDF.

Figures 4.8B and 4.8C examine the 40% PGDF in detail amongst

different modification of development. For ease of observation, Figure 4.8B was
split into each experimental group and displayed it in Figure 4.8C. Figure 4.8C
demonstrates the expression of the markers normalized to their expression in
PGD. Since all of the markers in Figure 4.8C are expressed at a value greater
than one, this indicates that the cells on the PGDF fiber significantly overexpress
these markers as compared to a PGD control. It is clear that expression of Nestin,
HB9 and ChAT was not significantly different between the two peptides but was
significantly overexpressed as compared to PGDF.

MAP2 and Olig2 were

significantly more expressed in the Laminin group than in the RGDC or PGDF
group. Surprisingly, ISL1 was higher expressed in the PGDF group than in either
of the peptide groups.

Examining the expression of GFAP there was no

significant difference between any of these three groups.
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Figure 4.8. Exp
pression of ne
eural lineage markers thro
ough real time
e-PCR. Resu
ults are stratifiied by
(A
A) diameter of
o fiber and (B
B, C) presenc
ce of either pe
eptide, no pe
eptide or no F
FA. In Figure
e 4.8A
an
nd 4.8B, exprression levels
s are normaliz
zed to the exxpression of h
housekeeping
g gene GAPD
DH. In
Figure 4.8C, expression
e
lev
vels are norm
malized to the
e expression of the same
e gene in the PGD
grroup. Average
e values and standard erro
ors are from tthree replicate
e experimentss.
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4.4 Discussion
Tissue engineering has emerged as an excellent strategy for developing
protocols to maximize neural regeneration in the peripheral nervous system.
Since cells cannot simply be introduced into the injury site on their own, a
supportive scaffold has become a necessary part of this technique. While a
scaffold may be effective for mimicking the physical, mechanical and
topographical properties of the cells, the presence of bioactive materials is
essential to provide continuing support to the implanted cells throughout the
duration of the repair process.
PGDF was chosen for this study since PGD has been demonstrated to
have sufficient biocompatibility, elasticity and the unique characteristic of shape
memory[143]. The addition of FA simply made the scaffold more amenable to
neural lineage survival due to its combination of neuroprotective effects and was
also crucial since the double bond in its chemical structure could be simply
broken to attach peptides of choice.

RGDC peptides were more efficient at

breaking the double bond than Laminin but only at a 50% and 60% PGDF
concentration. The composition of the polymer was essential for devising the
ideal scaffold, and increases in its concentration caused a resultant increase in
viscosity, leading to a larger fiber diameter. Previous research has demonstrated
an effect of fiber diameter and thus this was a factor that was chosen to be
modified in the experimental design of this study [181].
PGDF can be easily dissolved in a mixture of ethanol and water.

In

contrast, other synthetic polymers such as PLGA and PCL require more toxic
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and expensive solvents such as hexafluoro-2-proponol and trifluoroethanol [182].
Using this more straightforward dissolution method ensured that the fabrication of
fiber mats would not be a safety concern in the final implantation. This property
also simplifying the monitoring of the release of FA into the surrounding structure
over time via UV spectrophotometry.
In order to investigate the structural changes during polymer formation
and peptide binding, a combination of Raman spectroscopy and UV
spectrophotometry was used to check the presence of the internal structural
bonds. DDA and FA contain carboxylic groups at both ends and glycerol has
three free hydroxyl groups, all of which can be easily visualized in Raman
spectra. When polymerized, the formation of a new ester bond alongside the
removal of a water molecule allows the polymer to form branch structures in a
three dimensional network following the curing process. After peptides binding,
the decreased double bond concentration indicated that both RGDC and Laminin
peptides were attached to the fibers by breaking the double bond via Michael
addition.
To ensure that the polymer scaffold was effective for maintaining cell
survival, cell viability was tested using a Resazurin assay.

Mouse ESCs

differentiated into neural cell lineages due to the presence of FA on the fiber
alongside the RGDC and Laminin peptides. Both of the peptides group exhibited
similar cell viability during the whole differentiation process. On the contrary,
PGDF fiber scaffolds itself showed over twice difference than the other two
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groups. The confocal microscopy images also proved the importance of the
peptides binding on the scaffold regarding with cell viability.
When examining the results of real time PCR the findings were intriguing.
All of the following results were collected and normalized to PGD expression and
each of the experimental groups demonstrated far higher expression than PGD
control. These results indicated that the addition of FA alone was already a
significant improvement for inducing neural lineage differentiation. Within the
experimental groups, the expression of motor neuron marker HB9 and mature
motor neuron marker ChAT were upregulated by the presence of the peptides
over the PGDF alone. In addition, the neural stem cell marker Nestin was also
upregulated in both peptide groups over the PGDF alone. Laminin was far more
effective at upregulating the neuron marker MAP2 and the motor neuron
precursor Olig2 than the RGDC or PGDF groups, which were not significantly
different. Laminin is more frequently described as a differentiation factor than
RGDC, which is more commonly believed to be an attachment factor, and thus
these results are expected. The most surprising result was in the expression of
the motor neuron marker ISL1, where PGDF was found to express it significantly
higher than in either of the peptide groups. Previous research utilizing PDL and
PSHU polymers has indicated that a Laminin coating more effectively
upregulates ISL1 expression than an RGD coating, but it is unclear why the
PGDF alone produces higher expression than both of these groups
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CHAPTER 5 Conclusions and Future Work
Nerve regeneration is complicated and presents great challenges to
researchers. Tissue engineering provides an alternate strategy for nerve injuries.
This dissertation demonstrates a highly efficient motor neuron differentiation
protocol and a promising fiber scaffold for neural tissue engineering.
Chapter 2 addresses a highly efficient (65% of cells were HB9+ and 50%
of cells were ChAT+) and cost-effective method of generating mouse motor
neurons using metabolites comparing to the existing protocol (See Table 5.1). By
testing the efficiency of these small molecules as compared to traditional
approaches, we have begun to uncover the mechanisms by which oxidative
stress reduction and HDAC inhibition interplay to induce motor neuron
differentiation. These mechanisms have also been demonstrated to share an
underlying component – the down-regulation of glycolysis pathways – that hints
at a fundamental metabolic mechanism that can be used to derive novel
protocols for any stem cell differentiation approach. Using structural, molecular
and functional characterization techniques, the merits of this method this verified
and explored the impact of different molecular pathways, engaged through
metabolite introduction, on the expression of transcriptional factors, enzymes and
cytosolic markers.
Chapter 3 addresses the scaffold fabrication. PGD fiber scaffolds were
successfully produced by the electrospinning process and fiber diameter was
controllable through adjusting PGD concentration. The newly designed collector
allows us to easily obtain fibers with adequate length and integrity. Incorporating
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riboflavin into PGD/Gelatin fibers to promote the crosslinking process under UV
light was shown to improve fiber stability. The utilization of a solvent like ethanol
and water for electrospinning of PGD fibrous scaffolds provides a potentially less
toxic and more biocompatible fabrication method. Moreover, cell viability testing
demonstrated that the addition of gelatin leads to significant improvement of cell
proliferation on the scaffolds.
In Chapter 4, it is demonstrated that a novel PGDF scaffold modified with
RGDC and laminin peptides is beneficial for ensuring neural cell viability and
motor neuron differentiation. The natural release of FA into surrounding areas
was quantified to understand the bioreactivity of the derived scaffold. In
combination with UV crosslinking, the developed fiber mats will be able to
withstand degradation processes long enough for neural tissue engineering
applications to be viable. Cell viability and cell differentiation were demonstrated
to be significantly improved with the addition of FA, RGDC and laminin. In sum,
the combination of PGDF electrospun fiber scaffold and peptide immobilization
demonstrates a novel approach that provides a low-cost non-toxic methodology
for peripheral nervous system repair.
In future study, the new approach of using metabolites for motor neuron
differentiation will be further tested with other cell types such as hESCs and
iPSCs. Based on the results of mESCs and previous publications, these three
metabolites should have similar effects on different pluripotent cell types with
varied concentration and timing. The performance of these cells combined with
fiber scaffolds will be evaluated, in vitro and in vivo. We have demonstrated two
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different peptides that contributed to neural cell survival and differentiation. It will
be very interesting to test other types of peptides on this scaffold.
Table 5.1 Functional and phenotypic characteristics of MN derived from mESCs
References Cell line
Method to
MN
MN
Functional
induce MN
marker
differentiation test
differentiation
efficiency
Renoncourt mESCs,
Embryo Body ISL1,
40–60% of
N
et al., 1998 CCE line
(EB) treated
HB9,
Islet1+
[183]
with RA
ChAT
neurons;12%
and
of Islet1+
VAChT
were HB9+
Wichterle et mESCs,
EB treated
Hoxc6,
20–30% of
Y
al., 2002
HBG3 line with RA and
Hoxc7,
neurons were
[184]
SHH
Hoxc8,
HB9+
Nkx6.1,
Olig2,
Lhx3,
Lim1,
ISL1,
VAChT,
ChAT
Deshpande mESCs,
EB treated
Lhx3,
35–40% of
Y
et al., 2006 HBG3 line with RA and
HB9
neurons were
[185]
SHH
ChAT+
Hamada et mESCs,
EB treated
ISL1,
50% of
Y
al., 2006
E14.1 line with RA
Lim 1/2, MASH1
[186]
transfected
HB9
transfected
with
cells were
MASH1
Islet1+
neurons
LópezmESCs,
EB treated
ISL1,
15–20 % of
Y
González et HBG3 line with RA and
ChAT
neurons were
al., 2009
SHH
GFP+MN
[187]
Wu et al.,
mESCs
EB treated
ISL1,
40–50% MN
N
2011 [188]
from a
with Noggin,
HB9 and
SMA
RA and SHH ChAT
animal
model
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